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Kimberly M. Stratford: Vitamin D Deficiency and Air Pollution: Effects Impacting the 
Cardiovascular System 
(Under the direction of Mehdi Hazari) 
Human studies have shown that air pollution is associated with cardiovascular 
morbidity, yet the role of nutrition in modifying this susceptibility is unclear. Vitamin D 
deficiency (VDD) is a public health concern and the adverse consequences of its 
interaction with other stressors is understudied. VDD is linked to low levels of klotho, an 
anti-aging protein with a critical role in sinoatrial function. Transient receptor potential 
(TRP) channels are regulated by klotho and mediate cardiac effects to air pollution. 
TRPC6 is a cation channel that is physiologically inactive under normal conditions but 
upregulated with cardiovascular disease. I hypothesized that VDD changes 
cardiovascular function through mechanisms involving klotho and TRPC6 that mediate 
the responses to air pollution. First, I determined the effect of early-life VDD on 
cardiovascular responses to photochemical smog in mice. Three-week-old mice were 
placed on either a VDD or normal diet for 16-19 weeks and surgically implanted with 
biopotential radiotelemeters to continuously measure electrocardiogram, heart rate (HR) 
and whole-body plethysmography (WBP) for arrhythmias, heart rate variability (HRV) 
and ventilatory function. This study shows that VDD mice had decreased HR/tidal 
volume and increased HRV compared to controls and smog modulated the response. 
Second, I determined the role of klotho in VDD-induced adverse cardiac response to 
acrolein exposure. Mice were treated with recombinant klotho to determine if the 
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potentiated effects are blocked. This study demonstrates that compared to controls, 
HR/HRV was decreased in VDD mice. When compared to air exposure, acrolein 
increased HR/HRV and klotho blocked acrolein-induced effects in both diets. Lastly, I 
investigated the role of TRPC6 in VDD-induced cardiovascular mechanical responses. 
Dobutamine stress test was used to increase heart rate and reveal latent cardiac effects 
due to VDD and the involvement of TRPC6 in VDD mice was determined using an 
antagonist. Compared to controls, VDD mice have higher blood pressure and blunted 
HR response to dobutamine which was restored by TRPC6 antagonist. Future studies 
are needed to evaluate klotho and TRPC6 as potential therapeutic interventions. This 
project is the first to characterize the role of VDD as a nutritional modifiable factor in 
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Chapter 1: Introduction 
Health effects of air pollution 
The London Smog of 1952 and other such extreme events ignited the public’s 
awareness of air pollution and a scientific interest in studying the deleterious health 
outcomes of air pollution exposure.(Dooley 2002) London has had numerous episodes 
of terrible smog but the one in 1952 was the worst in terms of adverse human health 
effects, which resulted in approximately 12,000 “unnecessary” deaths. For five days in 
early December, increased industrial and fire emissions for heating, diesel combustion 
from buses combined with meteorological conditions created a perfect recipe for dense 
smog. All segments of the population were impacted, including the young, but especially 
the elderly who succumbed to bronchitis, pneumonia, and other respiratory diseases. 
Yet, although the relative number of cases presenting with respiratory symptoms was 
greater than any other complications, heart related adverse effects contributed to more 
deaths.(Dooley 2002) Most of this mortality was considered to be untimely because the 
overall risk in this population was not high.(Dooley 2002, Hunt, Abraham et al. 2003) In 
addition to mortality, retrospective studies have even linked early-life exposure to the 
London smog of 1952 to the development of asthma during adulthood.(Bharadwaj, Zivin 
et al. 2016) Unfortunately, complex multi-pollutant air pollution atmospheres like smog 
are still an environmental issue worldwide to this day, particularly for those with 
underlying health conditions. 
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Smog is a complex multi-pollutant mixture comprised of particulate matter (PM) 
of various sizes, gaseous components like ozone, volatile organic compounds (VOCs) 
and other chemicals. One of the greatest challenges to assessing the health effects of 
air pollution and assigning causality is due to the complexity and variability of 
composition, which can vary from place to place, and even from one season to another 
in a given area. Among the most ubiquitous gaseous pollutants, and indeed one of the 
most irritating to the airways, are the reactive aldehyde gases like acrolein (C3H40), 
which are produced by the combustion of any hydrocarbon-based fuel, fatty foods, 
biomass, cigarettes and other organic compounds to form a toxic, volatile unsaturated 
aldehyde.(Ghilarducci and Tjeerdema 1995, Kehrer and Biswal 2000, Conklin, 
Haberzettl et al. 2017) Acrolein inhalation causes nasal and pulmonary inflammation, 
(Snow, McGee et al. 2017)  eye, nose and throat irritation, (Sim and Pattle 1957, 
Esterbauer, Schaur et al. 1991)  respiratory distress (Ben-Jebria, Marthan et al. 1994, 
Bein and Leikauf 2011) and asthma exacerbations (Leikauf, Leming et al. 1989). Very 
high levels of acrolein (100-275 parts per million) have been shown to cause cardiac 
dysfunction and even mortality (Conklin, Haberzettl et al. 2017)  and recent data 
suggest that even lower levels of the gas can lead to subtle cardiovascular changes, not 
only in people with underlying disease but healthy individuals as well.   
Air pollution is associated with cardiovascular mortality 
Although air pollution was long considered a direct threat to the health of the 
respiratory system, especially the lungs, it has become clear that its effects go beyond 
the airways. In fact, the American Heart Association (AHA) has released a statement in 
2010 alerting people to the hazardous effects of air pollution. (Brook, Rajagopalan et al. 
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2010) In the last twenty years, cardiovascular morbidity and mortality have been 
demonstrated to be strongly correlated with short and long term ambient air pollution 
exposure (Brook, Rajagopalan et al. 2010), particularly in the presence of underlying 
cardiovascular disease (e.g. hypertension). (Hazari, Callaway et al. 2012, Rajagopalan 
and Brook 2012, Hazari, Griggs et al. 2014) Scientific data points to the fact that several 
major components of air pollution, particularly particulate matter (PM), can contribute to 
these effects. The Environmental Protection Agency (EPA) has identified and regulates 
six of these pollutants: ground level ozone, nitrogen dioxide, PM, lead, carbon monoxide 
and sulfur dioxide. Each of the criteria pollutants, along with the constituent polycyclic 
aromatic hydrocarbons (PAHs), VOCs and other environmental contaminants have the 
potential to react and cause a synergistic, or even antagonistic, effect on cardiac health. 
Therefore, the cardiovascular response to mixtures of air pollutants is still being 
characterized and requires a significant amount of work. (Brook, Rajagopalan et al. 
2010) 
Studies have conclusively linked fine PM, which is less than 2.5 µm (PM2.5), and 
coarse PM (PM10) to adverse health effects. In particular, PM2.5 is produced by 
combustion of fossil fuels for human activities and short and long-term exposure to it 
has been shown to contribute to the early death of thousands of Americans every year. 
Similarly, hospitalization rates for arrhythmias, heart failure and cerebrovascular 
disease have been shown to increase for 24 hours after high PM2.5 days and for 48 
hours in individuals with previous myocardial infractions. (Brook, Rajagopalan et al. 
2010) Although the focus of many studies of the adverse cardiovascular effects of air 
pollution has traditionally been on PM, gaseous environmental contaminants also 
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contribute to cardiovascular dysfunction.(Chiu, Weng et al. 2017, Coogan, White et al. 
2017, Costa, Hoek et al. 2017, Day, Xiang et al. 2017, Mirowsky, Carraway et al. 2017, 
Yang, Qian et al. 2017) For example, ozone exposure causes systemic inflammation, 
(Mirowsky, Carraway et al. 2017) platelet stimulation, (Day, Xiang et al. 2017) 
hypertension (Coogan, White et al. 2017, Day, Xiang et al. 2017) and hospital 
admissions due to myocardial infarctions (Chiu, Weng et al. 2017) which are all major 
contributing factors to cardiovascular morbidity and mortality.  
There are three biological mechanisms that have been proposed as mediating 
the cardiovascular response to air pollution. This includes 1) pulmonary oxidative stress 
and inflammation which can spread beyond the lungs, 2) autonomic nervous system 
imbalance, which has the potential to disrupt the normal function of not only the 
respiratory and cardiovascular systems, but also the digestive and endocrine systems 
as well, and the 3) translocation of PM and/or other components into the blood towards 
secondary target sites. Epidemiological, human and animal studies have greatly 
contributed to the weight of evidence for these biological mechanisms. Each of these 
pathways is highly complex and not likely taking place independently. In fact, vascular 
dysfunction, increased coagulation, and hypertension combined have been 
demonstrated to elicit adverse cardiovascular events in human and animal studies. 
(Brook, Rajagopalan et al. 2010)  
Heart disease prevalence 
So, why is an inhaled exposure to air pollution so concerning when it comes to 
the cardiovascular system, particularly if it is short-term? Part of the answer to this 
question lies in the prevalence of cardiovascular disease in the developed world. 
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Cardiovascular disease is the leading cause of mortality in the United States and is an 
all-encompassing term that includes atherosclerosis, hypertension, myocardial 
infarction, stroke, heart failure, and arrhythmia. Cardiovascular mortality rates in 2007 
were 259.4 per 100,000 people and decreased to 223.9 per 100,000 people in 2013 
which is an improvement of about 13.7%. (Mozaffarian, Benjamin et al. 2016) However, 
cardiovascular disease still affects 30% of the US population and is an immense 
economic and societal burden. (Mozaffarian, Benjamin et al. 2016, Trehan, Afonso et al. 
2017) In addition, lifestyle and other factors which are not always fully appreciated are 
contributing to the more rapid progression of the disease. This suggests that there is a 
heightened susceptibility in a certain percentage of the population due to the presence 
of these factors.   
Autonomic nervous system and heart rate variability 
Cardiovascular function is intrinsically regulated by the autonomic nervous 
system (ANS), which is comprised of two major branches, the parasympathetic and 
sympathetic, that dynamically interact and simultaneously modulate function depending 
on the physiological state of the body and the environmental conditions or stimuli. 
(Thayer, Yamamoto et al. 2010, Shen and Zipes 2014) Parasympathetic tone of the 
autonomic nervous system is typically characterized as the “rest and digest” state and is 
critical for everyday basal bodily functions. In contrast, sympathetic tone represents the 
“fight or flight” state, which causes heart rate accelerations, regulation of blood pressure 
to accommodate stress and reduction of activities normally occuring during rest (e.g. 
digestion). Nerves of the autonomic nervous system originating from the brainstem 
innervate the heart to maintain sinus heart rhythm and when necessary modulate it to 
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respond to a given stressor (e.g. exercise). (Shen and Zipes 2014) Abnormal 
dominance of one branch over the other or inappropriate modulation during a given 
circumstance is called autonomic imbalance and it generally reflects the body’s inability 
to either maintain homeostasis or compensate for change. (Tsuji, Larson et al. 1996, 
Brook and Julius 2000, Thayer, Yamamoto et al. 2010) Furthermore, the ANS is also 
modulated by chemoreflexes which respond to decreases in blood oxygen or increases 
in carbon dioxide by increasing sympathetic modulation, and baroreflexes, which are 
activated by blood pressure changes and result in parasympathetic activation. These 
control mechanisms alter heart rate, contractility and vasoconstriction/dilatation, as well 
as breathing patterns. (Kara, Narkiewicz et al. 2003, Heusser, Tank et al. 2005) 
Therefore, any persistent changes to normal autonomic function would impact the 
regulatory outflow of these reflexes and thereby impact the response of the target 
tissues.  
Heart rate variability (HRV) is used clinically to assess autonomic tone of the 
heart and is based on the evaluation of beat-to-beat or R-R interval, which represents 
the duration of cardiac cycle. (Tsuji, Larson et al. 1996) It is not only determined by 
normal physiological signals (e.g. renin-angiotensin cascade, release of 
neurotransmitters and metabolic hormones) but also pathological conditions (e.g. 
cardiomyopathy and myocardial infractions) as well. (Tsuji, Larson et al. 1996, Brook 
and Julius 2000) Heart rate variability is measured using time and frequency domain 
parameters that are commonly used to represent the two branches, these parameters 
are constantly changing based on fluctuations of bodily activity. The time domain 
measures of HRV are standard deviation of the normal R-R interval (SDNN) and root 
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mean square of the standard deviation of the normal R-R interval (RMSSD). SDNN is 
commonly used to evaluate overall autonomic function while RMSSD indicates 
parasympathetic modulation. The frequency domain measures of HRV are low 
frequency (LF) and high frequency (HF). There is considerable debate about the 
interpretation of LF, however, in general current literature suggests that it represents 
both the sympathetic and parasympathetic influence on the heart. On the other hand, 
HF is a reliable indicator of parasympathetic tone. Some studies report the ratio of 
LF/HF as an indicator of the balance of sympathetic and parasympathetic activity. 
(Thayer, Yamamoto et al. 2010)  
Heart rate variability and cardiovascular disease 
Abnormal HRV represents a latent change in cardiac function particularly in 
instances when symptoms of dysfunction are not otherwise evident. (Stein, Domitrovich 
et al. 2005) Therefore, clinicians commonly use HRV to assess cardiac health or 
prognosis and risk of mortality, especially after an adverse cardiac event.(Thayer, 
Yamamoto et al. 2010)  On the other hand, it is important to note that changes in HRV 
may not solely be due to ANS modulation but could also be explained by modified 
cardiac receptor and myocardium function. (Rowan, Campen et al. 2007) As such, 
epidemiological studies have repeatedly linked cardiac abnormalities with low HRV (i.e. 
increased sympathetic modulation), which indicates the heart is unable to respond to 
changing circumstances (i.e. lower variability and ability to modulate). (Brook, 
Rajagopalan et al. 2010) In addition, low HRV especially at rest, suggests that there is 
greater risk of an adverse cardiac event because the heart is in a higher state of 
persistent stress than normal. In contrast, many animal studies link greater HRV to air 
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pollution exposure and a shift away from the normal homeostatic cardiac response. 
(Brook, Rajagopalan et al. 2010, Farraj, Hazari et al. 2011, Hazari, Callaway et al. 2012, 
Carll, Lust et al. 2013, Hazari, Griggs et al. 2014, Kurhanewicz, McIntosh-Kastrinsky et 
al. 2014, Stratford, Haykal-Coates et al. 2018) Therefore, it is clear that a change in 
HRV alone is not sensitive enough to diagnose cardiac disease or dysfunction and 
should be evaluated in combination with other clinical tests.  
Rodent HRV effects can be extrapolated to human HRV if the responses are 
assessed in light of differences in basic physiology (i.e. determinants of resting heart 
rate), sampling duration, circadian rhythm effects, usage of anesthesia and thermal 
responses. In such a case, the utility of evaluating HRV in rodents is due to the 
fundamental mechanisms of the cardiac regulation being similar to humans. (Rowan, 
Campen et al. 2007)  
Given the two branches are essential to the proper function of the heart and that 
a dynamic balance must be maintained, extremes in either parasympathetic or 
sympathetic activity can also increase mortality. (Gold, Litonjua et al. 2000) Sometimes, 
this autonomic imbalance is only evident if the body is exposed to a stressor (e.g. air 
pollution exposure), which forces the heart to adapt and change its function accordingly. 
(Thayer, Yamamoto et al. 2010, Carll, Crespo et al. 2017) 
Heart rate variability and air pollution exposure 
Even under acute conditions, ambient air pollution can cause relatively subtle or 
latent changes in HRV or electrical disturbances (i.e. arrhythmia) indicative of increased 
cardiovascular risk. Even in healthy young subjects, exposure to air pollution increases 
parasympathetic tone of the ANS compared to clean air suggesting autonomic 
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imbalance. (Davoodi, Sharif et al. 2010) Additionally, animal studies have consistently 
demonstrated that air pollution induces autonomic modulation that contributes to 
alterations in cardiac electrophysiology which are further exacerbated following stress. 
(Farraj, Hazari et al. 2011, Hazari, Callaway et al. 2012, Kurhanewicz, McIntosh-
Kastrinsky et al. 2014) Therefore, HRV might be thought of less as a marker of 
cardiovascular toxicity and more as an indicator of the internal state of the 
cardiovascular system and its relative ability to adapt to changing conditions. This is a 
critical point to understand because there are numerous factors that have the potential 
to influence autonomic regulation of the cardiovascular system. 
Modifiable factors influence responsiveness to air pollution exposure 
Historically, the paradigm for air pollution toxicology involved measuring the 
response of a given target tissue to a certain dose of pollutant still remains the case 
today. However, the field has evolved due to the recognition that changing lifestyles and 
other factors have the potential to change the way the body responds to an insult. In 
particular, the cardiovascular health effects of air pollution may differ from one person to 
another due to modifiable factors, despite similarities in age, gender and background, 
and may help explain divergent responses. (Requia, Adams et al. 2017) The American 
Heart Association defines ideal cardiovascular health as the absence of disease and the 
presence of seven key health factors that they term life’s simple seven: smoking status, 
body mass index, physical activity, healthy diet, total cholesterol, blood pressure and 
blood glucose. (Mozaffarian, Benjamin et al. 2016) Life’s simple seven are common 
modifiable factors that influence cardiovascular health and maintenance of a healthy 
diet is particularly important. In fact, data from the National Health and Nutrition 
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Examination Survey (NHANES) points to the prevalence of cardiovascular health 
factors in U.S. children and adults, and it shows that 63.4% of U.S. kids have poor diets 
that extends into adulthood among whom 30-50% will also have poor diets. 
(Mozaffarian, Benjamin et al. 2016) This suggests that children with poor diets (i.e. 
nutritional deficiencies) might continue on that path and become adults with poor diets; 
thus, chronically influencing the state of the body and responsiveness to air pollution 
exposure. 
Vitamin D 
One of the essential micronutrients that affects various functions throughout the 
body is vitamin D, which is endogenously synthesized by the skin and obtained from the 
diet (e.g. salmon, tuna, eggs, cheese, milk and fortified foods).(Holick 2007, Trehan, 
Afonso et al. 2017) As shown in Figure 1-1, 7-dehydrocholesterol is produced by UV 
light radiation and converted to cholecalciferol (vitamin D3) which is also obtained 
through dietary intake of animal products. The liver then hydrolyzes vitamin D 
precursors using a cytochrome P450 enzyme (CYP27A1) to produce calcidiol or 25-
hydroxyvitamin D, which is a key circulating biomarker of vitamin D. Calcidiol is 
hydrolyzed in the kidneys by 25-hydroxyvitamin D-1-alpha hydroxylase or CYP27B1 to 
produce the active vitamin D hormone termed calcitriol or 1-alpha, 25-dihyroxyvitamin D 
(1,25(OH)2D). (Holick 2007, Berridge 2015, Rai and Agrawal 2017, Trehan, Afonso et 
al. 2017) The main function of calcitriol is to maintain calcium balance in the body. 
Calcitriol is tightly regulated by secretion of parathyroid hormone (PTH) which responds 




Figure 1-1. Comprehensive vitamin D synthesis pathway. 
 
The vitamin D receptor (VDR) is a steroid nuclear receptor found throughout the 
body including osteoblasts, intestinal enterocytes and cells of immune and nervous 
systems. (Wang, Pencina et al. 2008) The VDR was identified in vivo and in vitro using 
the rat heart and atria-cultured cardiac cells, respectively. (Baksi , Walters) Vitamin D 
exerts its effects through the VDR and upon activation forms a complex with the retinoid 
X receptor (Figure 1-2), (Holick 2007, Fetahu, Höbaus et al. 2014, Norman and Powell 
2014, Saccone, Asani et al. 2015), which then binds to vitamin D response elements 
(VDRE) on DNA and influences expression of a wide variety of genes covering 
numerous functions (e.g. calcium homeostasis, antioxidant production, protein 
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synthesis). (Sundar and Rahman 2011, Fetahu, Höbaus et al. 2014, Norman and 
Powell 2014, Saccone, Asani et al. 2015) Thus, vitamin D is essential for homeostasis 
and proper physiological function. For example, vitamin D regulates genes involved in 
bone turnover, detoxification, antioxidant defense and immune system modulation. 
Therefore, a deficiency in vitamin D leads to potentially adverse changes in the body, 
which may go unnoticed due to subtle alterations in physiology. 
 
 
Figure 1-2. Schematic of the vitamin D receptor activation pathway that leads to 
gene transcription. 
Vitamin D deficiency 
Vitamin D deficiency (VDD) is a global epidemic affecting approximately one 
billion children and adults alike worldwide. (Trehan, Afonso et al. 2017) There is some 
contention regarding the serum level of vitamin D that is defined as “deficient” but 
typically it is accepted to be < 20-30 ng/ml (Figure 1-3). There are myriad of causes of 
VDD including diminished vitamin D synthesis in the skin, which is the most well-known 
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and decreased production of vitamin D precursors, renal/liver organ failure and 
malabsorption conditions. (Holick 2007) Low serum levels of vitamin D has been 
observed in chronic kidney disease suggesting an association between vitamin D status 
and organ dysfunction as well as impaired VDR activation. (Dusso 2011) 
 
Figure 1-3. Recommended serum vitamin D reference range.  
Vitamin D deficiency and cardiovascular disease 
The consequences of VDD are present throughout the body. Traditionally, VDD 
has been associated with bone conditions but depression, infections, neuro-
degenerative/neuromuscular diseases, diabetes and cancer are lesser known 
outcomes. (Holick 2007, DeLuca, Kimball et al. 2013, Muscogiuri, Annweiler et al. 2017)  
More recently, interest in VDD’s contribution to cardiovascular disease has grown. 
(Holick 2007, Lee, O'Keefe et al. 2008, Muscogiuri, Annweiler et al. 2017) Previous 
studies have linked decreased serum vitamin D levels to stroke, myocardial infarction, 
heart failure and subsequent cardiovascular related death. (Pilz, März et al. 2008) In 
particular, epidemiological studies have demonstrated that VDD is associated with 
increased cardiovascular risk and subsequent myocardial infarction, atherosclerosis and 
stroke. In elderly stroke patients, VDD at the start of stroke has been shown to be 
correlated to increased likelihood of death after one year. (Muscogiuri, Annweiler et al. 
2017) Similarly, data from NHANES suggests that VDD is a risk factor for 
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cardiovascular disease due to adverse effects in the heart. (Al-Khalidi, Kimball et al. 
2017)  
Vitamin D deficiency and the heart 
One of the most common cardiovascular conditions in the U.S. is hypertension, 
and although many cases are linked to high salt intake, stress, or familial genetic 
disposition, vitamin D status also might play a role. People with high blood pressure are 
at increased risk of developing heart diseases (e.g. congestive heart failure, cardiac 
hypertrophy, stroke). When combined, hypertension and VDD further increase 
probability of cardiovascular disease compared to non-hypertensive VDD individuals as 
demonstrated by a prospective study (Figure 1-4). (Lee, O'Keefe et al. 2008) Previous 
experimental studies have demonstrated that vitamin D inhibits renin production and 
reduces activity of the renin-angiotensin-aldosterone system (RAAS) activity leading to 
lower blood pressure. However, VDD results in excess renin production and potentiates 
RAAS activity leading to hypertension.(Li, Kong et al. 2002, Li, Qiao et al. 2004, Trehan, 
Afonso et al. 2017) Additionally, PTH, which is also increased in VDD, also stimulates 
renin and aldosterone release to increase RAAS activity and vascular contractility and 
induce increased pressure. (Carbone, Mach et al. 2014) Interestingly, the incidence of 
hypertension and VDD is increasing in the United States, with evidence also pointing to 
increased risk for hypertension among VDD individuals. (Martins, Wolf et al. 2007, 
Scragg, Sowers et al. 2007, Forman, Curhan et al. 2008, Judd, Nanes et al. 2008, Lee, 





Figure 1-4. Hypertensive vitamin D deficient individuals have increased 
probability of cardiovascular disease compared to non-hypertensive vitamin D 
deficient individuals. (Reproduced from Lee et al., 2008) 
Although many of the cardiovascular conditions observed in the United States 
involve intrinsic abnormalities in the heart or vasculature, extrinsic factors may also 
contribute to the development of disease. Vitamin D may influence the ANS, which is 
critical in maintaining and regulating cardiovascular function. The VDR is highly 
expressed on neurons in the brainstem suggesting a prominent role for the vitamin D. 
(Dimova, Tankova et al. 2017) This is highlighted by the fact that neurotransmitter 
synthesis is also regulated by vitamin D, particularly acetylcholine, serotonin and 
dopamine, which are important in the function of the ANS. (DeLuca, Kimball et al. 2013) 
During times of stress, the parasympathetic nervous system is typically inhibited but 
VDD has been shown to prevent this inhibition, possibly due to the vitamin’s role in the 
central nervous system. (Dimova, Tankova et al. 2017) Thus, autonomic imbalance 
even in otherwise healthy VDD individuals may set the stage for cardiac dysfunction in 
the long-term. (Canpolat, Özcan et al. 2015) To better understand the relationship 
between VDD and cardiovascular disease, and how VDD causes these deficits, the 
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mediators and the pathways involved in the vitamin D effects on the cells of the body 
need to be studied. 
Klotho 
Recent studies have shown that the cardiac effects of vitamin D are mediated 
through the production and release of klotho. Klotho was identified as an anti-aging 
gene in 1997 using mutated mouse strains that developed atherosclerosis, osteopenia, 
emphysema, skin atrophy and shortened lifespans. (Matsumura, Aizawa et al. 1998) 
Due to the pre-mature aging phenotype associated with this gene, it was termed klotho 
after the Greek goddess spinning the thread of life. (Strewler 2007) It is an anti-aging 
transmembrane protein that is cleaved and enters systemic circulation and has been 
found in blood, serum and cerebrospinal fluid. (Imura, Tsuji et al. 2007, Strewler 2007) 
The soluble form of klotho, which can form a dimer, activates a myriad of cellular 
signaling pathways including those involved in antioxidant defense, enzymatic 
detoxification, inflammation and regulation of cationic channels like transient receptor 
potential (TRP). (Berridge 2015) Additionally, there are two forms, α- and β-klotho, the 
form used in these studies is α-klotho.(Imura, Tsuji et al. 2007) Klotho receptors have 
not been identified but binding to monosialogangliosides (acidic glycosphingolipid with 
sialic acid) in lipid rafts are thought to act as potential receptors for klotho. On the other 
hand, klotho also binds to sialic acid residues on certain cation channels (e.g. TRP 
channels) and exhibit hormone-like properties. (Dalton, An et al. 2017) 
Klotho and calcium 
Klotho is expressed in numerous tissues in the body including the kidneys, 
parathyroid gland and choroid plexus of the brain, all of which have substantial 
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involvement in calcium homeostasis. (Matsumura, Aizawa et al. 1998) Interestingly, it 
was noted that klotho deficient mice have elevated calcium, phosphate and vitamin D 
levels suggesting that the body tries to compensate for the lack of klotho by increasing 
vitamin D levels. (Strewler 2007, Berridge 2015) Regardless, klotho deficiency results in 
a premature aging phenotype (e.g. shortened lifespan, atherosclerosis, osteoporosis) 
and there are several mechanisms implicated in the subsequent development of 
dysfunction. For example, organ calcifications particularly in the kidneys can lead to 
typical symptoms of osteoporosis. (Strewler 2007) Moreover, klotho’s role in calcium 
homeostasis is likely mediated by Na+-K+-ATPase, which is a membrane binding 
protein recruited to the plasma membrane in response to calcium signaling with klotho 
being required in the pathway. Klotho may also play a role in PTH secretion through the 
same Na+-K+-ATPase pathway described above. (Imura, Tsuji et al. 2007) This data 
suggests that the characteristic decrease in PTH in VDD could be mediated by 
disruption of Na+-K+-ATPase recruitment to the plasma membrane in response to 
calcium signaling. Additionally, klotho has a negative regulatory feedback mechanism to 
maintain calcium homeostasis.  
Klotho and the heart 
Recent studies suggest that klotho has cardioprotective effects (Takeshita, 
Fujimori et al. 2004), either through the prevention of oxidative stress,(Yang, Wang et 
al. 2015) or inhibition of TRP channels (Xie, Cha et al. 2012) and RAAS activation 
(Eltablawy and Ashour 2018). Additionally, klotho deficient mice have increased left 
ventricular pressure and hypertrophy,(Hu, Shi et al. 2011) likely due to premature 
activation of components of RAAS,(Zhou, Mo et al. 2015, Yu, Meng et al. 2016, Yang 
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and Xu 2017) as well as neurological deficits which might contribute to autonomic 
dysfunction (Cararo-Lopes, Mazucanti et al. 2017). Klotho has been shown to be 
expressed in the sinoatrial node region (i.e. the pacemaker) of the heart and plays a 
critical role during stress (Takeshita, Fujimori et al. 2004) and even characterized as a 
biomarker of acute stress (Abdelmalik, Stevens et al. 2018). Wild-type mice at baseline 
have a normal heart rate and electrocardiogram, but have increased heart rate and 
normal electrocardiogram changes during restraint stress. In contrast, klotho deficient 
mice also have a normal heart rate response at baseline but during restraint stress 
these mice develop a sinoatrial node arrhythmia, which is likely due to altered cation 
channel function. Interestingly, the same sinoatrial node arrhythmia has been reported 
in mice exposed to air pollution. (Takeshita, Fujimori et al. 2004, Stratford, Haykal-
Coates et al. 2018) Therefore, it appears that the bulk of VDD cardiovascular effects 
may revolve around the regulation and flux of calcium in and out of cells due to altered 
cation channel properties. 
Transient receptor potential channel C6 (TRPC6) 
One of the cation channels present in the heart and regulated by klotho is 
transient receptor potential C6 (TRPC6) cation channel. Transient receptor potential 
channels are non-selective, non-voltage gated cation channels that are important in 
cardiovascular disease (Figure 1-5). (Dietrich, Steinritz et al. 2017) (Watanabe, 
Murakami et al. 2009, Rowell, Koitabashi et al. 2010) The canonical TRP family 
includes TRPC6, under normal conditions has low expession, but it is upregulated in 
cardiac diseases and cardiac myopathy. (Rowell, Koitabashi et al. 2010, Xie, Cha et al. 
2012, Loga, Domes et al. 2013, Watanabe, Iino et al. 2013, Seo, Rainer et al. 2014) 
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TRPC6 is activated by mechanical and oxidative stress. (Seo, Rainer et al. 2014) 
Mechanical stress is characterized by frictional force that causes muscular stretching, 
which in turn activates the channel. (Davies 2009) Activation of TRPC6 results in 
alterations of calcium membrane potentials that drive calcium transport into the cell, 
resulting in increased contractility. (Watanabe, Murakami et al. 2009, Watanabe, Iino et 
al. 2013) In VDD, higher blood pressure or mechanical stress overload might stimulate 
an increase in calcium due to the potentiated TRPC6 activation. All of this occurs 
because the myocardium must stretch to allow for blood to eject against the increased 
mechanical load. Consequently, if this process is sustained, there is a likelihood that 
cardiac hypertrophy and eventually heart failure will occur. (Yamaguchi, Iribe et al. 
2017) In fact, increased expression of TRPC6 (and TRPC3) has been found in the heart 
as well as in the vascular smooth muscle and endothelium cells of humans and rodents 
prone to heart failure. (Loga, Domes et al. 2013, Watanabe, Iino et al. 2013, 
Yamaguchi, Iribe et al. 2017) Abnormal calcium signaling in the brain (Sawamura, 
Shirakawa et al. 2017) and kidneys (Wu, Xie et al. 2017) , due to other factors, also 
causes increased TRPC6 leading to dysfunction. Therefore, expression of TRPC6 
increases due to stress (e.g. mechanical stress or exercise) and appears to result in 




Figure 1-5. Schematic of transient receptor potential channel C6 (TRPC6). 
(Reproduced from Dietrich et al, 2017) 
Klotho and TRPC6 
Chronic high blood pressure and other similar cardiovascular conditions are 
dangerous not only because of the vascular effect but also because of the resulting 
mechanical changes on the heart due to sustained pressure overload. Studies have 
demonstrated that TRPC6 inhibition prevents cardiac hypertrophy from pressure load 
and is a potential therapeutic target. (Xie, Cha et al. 2012, Seo, Rainer et al. 2014) The 
stress that pressure overload puts on the heart is characterized by abnormal calcium 
signaling and upregulation of TRPC6, which can be considered a feedback loop. Under 
such circumstances, not only is the function of the heart altered at rest (i.e. baseline 
contractile characteristics) but also if the body encounters a stressor like exercise. 
Recent studies show that in klotho deficiency and subsequent pressure overload 
conditions, TRPC6 expression and cation influx are upregulated. (Frohlich and Susic 
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2012, Xie, Cha et al. 2012) This data suggests that the calcium signaling pathways in 
normal and pressure-overload hearts are distinct and that VDD may result in the latter 
due to the coexisting hypertension. 
Cardiac stress test 
The cardiovascular system operates just like all the other organ systems in that it 
maintains physiological processes and responds to the metabolic demands of the body. 
In particular, increases in heart rate and contractility, and changes in 
vasodilatation/constriction modify the flow of oxygenated blood to the tissues that need 
it the most (i.e. demand). Luckily the cardiovascular system is well equipped to respond 
to stress due to additional reserve capacity, when work rate, oxygen consumption and 
metabolic demand increase greatly. Evaluating this ability to compensate using a 
cardiac stress test can help clinicians diagnose the presence of underlying heart 
disease and at times the etiology of symptoms (e.g. angina). (Iyngkaran, Anavekar et al. 
2017, Koyner and Chawla 2017) The purpose behind this approach is to uncover a 
latent change in the body which may be hidden or otherwise unnoticed. Although this is 
often achieved by an exercise challenge like walking or even running on a treadmill, 
dobutamine, whichi s beta-adrenergic receptor agonist, can be used to increase heart 
rate and contractility. Previous studies suggest that dobutamine administration mimics 
the cardiac effects of exercise and we have previously demonstrated that this form of 
challenge testing uncovers the harmful underlying effects of air pollution. (Hazari, 
Callaway et al. 2012, Kieu, Shaikh et al. 2017) Therefore, its use in this setting is not 
only suitable for the purposes of measuring cardiovascular toxicity but also mimicking 
what might be observed in a person. 
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Scope of dissertation 
Epidemiological, human and animal data have linked adverse cardiovascular 
outcomes to air pollution exposure. Yet, it is only recently that toxicologists have begun 
to focus on the role of other factors due to the fact that the effects of today’s ambient air 
pollution may not be perceivable. In other words, are there latent effects to the body 
despite the lower levels of air pollution in the United States and other developed 
countries and are those effects exacerbated in the presence of underlying deficiencies 
or disease. Although conditions like asthma and metabolic syndrome have been studied 
extensively in the context of air pollution, other conditions, like micronutrient 
deficiencies, have not. Part of the reason these maladies are not addressed with 
respect to cardiovascular dysfunction is the lack of conclusive evidence suggesting 
there is a link. Despite this, there is sufficient data suggesting that micronutrient 
deficiencies like VDD cause underlying physiological changes which alter the body’s 
ability to respond to fluctuations in environmental conditions and insults even if they do 
not directly cause disease. Therefore, studies need to examine the impact of conditions 
like VDD or other public health concerns such as folate deficiency, in order to uncover 
whether there is a heightened susceptibility for an adverse response. Furthermore, 
characterization of the mechanism by which VDD causes these cardiac effects will 
provide biological plausibility and aid in the risk assessment process. The project 
described herein can begin to contribute to this effort. The impact of early-life VDD in 
this paradigm has not yet been determined and air pollution is likely the type of 
ubiquitous environmental stressor that causes adverse cardiovascular effects and 
overall decrements in public health. The goal of my dissertation is to understand how 
VDD alters cardiovascular responses to air pollution and further determine the role of 
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klotho and TRPC6 in mediating such responses (Figure 1-6). Therefore, the central 
hypothesis of this project is that VDD changes the cardiovascular response to air 
pollution through mechanisms involving klotho and TRPC6. 
 
Figure 1-6. Schematic of dissertation approach. Chapter 2 and 3 will address the 
effect of early-life VDD on the cardiovascular response to air pollution exposure in adult 
mice. Chapter 3 will describe the role of klotho in VDD-induced acrolein exposure 
effects. Next, the effect of VDD on the mechanical function of the heart and the role of 
TRPC6 is explored in chapter 4. 
 
To test this hypothesis, the following specific aims were examined.  
1. Describe the effect of early-life VDD on the cardiovascular response to 
photochemical smog exposure in adult mice. 
2. Describe the role of klotho in VDD-induced adverse cardiac response to acrolein 
in adult mice. 
3. Describe the role of TRPC6 in VDD-induced cardiovascular mechanical 
responses in adult mice. 
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Specific Aim 1: Chapter 2 will describe the effect of early-life VDD on the 
cardiovascular response to photochemical smog exposure in adult mice. 
There is growing evidence that VDD, which is now a worldwide public health concern, 
leads to an increased risk of cardiovascular disease. Yet it is still unclear whether it 
exacerbates the deleterious cardiovascular effects (e.g. arrhythmia, hypertension, fatal 
heart attacks) of environmental stressors like air pollution, particularly when it persists 
from early-life to adulthood. I hypothesize that persistent early-life VDD alters cardiac 
function and modifies the response of adult mice to smog.   
Specific Aim 2: Chapter 3 will describe the role of klotho in VDD-induced adverse 
cardiac response to acrolein in adult mice.  
Klotho is an anti-aging protein expressed in the sinoatrial node region of the heart with a 
critical role during stress, and is also suggested to be a mediator in vitamin D effects 
throughout the body. Klotho deficient mice have shortened lifespans, vascular 
calcifications and susceptibility to arrhythmia. Additionally, VDD mice have lower klotho 
mRNA expression in the heart. I hypothesize that treatment with klotho blocks the 
cardiovascular response of vitamin D deficient mice to acrolein. 
Specific Aim 3: Chapter 4 will describe the role of TRPC6 in VDD-induced 
cardiovascular mechanical responses in adult mice. 
Overexpression of TRPC6 has been shown to be associated with certain cardiovascular 
diseases, particularly those with pressure-overload, and is also believed to be increased 
in VDD. In this study, my goal is to determine the effect of VDD on the mechanical 
function of the heart both at rest and during dobutamine stress test. I hypothesize that 
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the changes in cardiovascular mechanical function in adult mice due to early-life 
persistent VDD are mediated by TRPC6.  
Main objective of this dissertation 
The results of this project are expected to improve our understanding of the role 
of VDD, a common worldwide public health problem, in the development of 
cardiovascular disease and air pollution-induced cardiovascular toxicity. The relevance 
of this work to public health will be further established through on-going collaborations 
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Chapter 2: Early-Life Persistent Vitamin D Deficiency Alters Cardiopulmonary 
Responses to Particulate Matter-Enhanced Atmospheric Smog in Adult Mice1 
Introduction 
It is clear from epidemiological, human and animal studies that air pollution has a 
deleterious effect on cardiovascular health (e.g. ischemic heart disease, arrhythmia, 
stroke). (Brook, Rajagopalan et al. 2010) In fact, research from the last ten years has 
shown that there are several factors, which include not only those related to air pollution 
such as concentration, composition and chemistry, but also host factors like nutrition, 
that contribute to the overall response. Thus, characterization of these factors with the 
intent of understanding the underlying toxicological mechanisms as well as providing 
useable public health information about individual susceptibility is crucial to reducing the 
harmful effects of air pollution particularly given the prevalence of chronic diseases like 
asthma and heart disease. 
 Like all the organ systems, regulation and proper function of the cardiovascular 
system is dependent on adequate levels of micronutrients like vitamin D, which is one of 
a few molecules with a critical homeostatic role throughout the body. (Holick 2007, Lee, 
O'Keefe et al. 2008)  
1This chapter previously appeared as an article in the Journal of Environmental Science 
and Technology. The original citation is as follows: Stratford, K., N. Haykal-Coates, L. 
Thompson, Q. T. Krantz, C. King and J. Krug (2018). "Early-Life Persistent Vitamin D 
Deficiency Alters Cardiopulmonary Responses to Particulate Matter-Enhanced 




Although recent data supports the relationship between VDD and cardiovascular 
impairment (Wang, Pencina et al. 2008, Anderson, May et al. 2010, Masson, Agabiti et 
al. 2014), the link to cardiovascular disease development is still not firmly established 
nor is it clear whether it contributes to adverse responses due to air pollution. Vitamin D 
(Vitamin D3) is a fat-soluble vitamin produced endogenously in the skin, after ultraviolent 
B radiation exposure, and acquired through the diet from a variety of foods like milk, 
fish, cheese and beans.(Lips 2006, Holick 2007) Vitamin D receptors are present on 
numerous tissues and cells throughout the body, including cardiomyocytes.(Holick 2007) 
Minimal sun exposure, obesity, improper nutrition as well as a myriad of other factors 
result in vitamin D deficiency (VDD)(Holick 2007, Lee, O'Keefe et al. 2008), which has 
become a public health concern affecting 8% of the pediatric population in the United 
States.(Kumar, Muntner et al. 2009) Early-life or childhood VDD can lead to vascular 
dysfunction, hypertension and other cardiac abnormalities(Carlton-Conway, Tulloh et al. 
2004, Maiya, Sullivan et al. 2008, Tare, Emmett et al. 2011), yet it’s precise role in 
electrocardiographic abnormalities and cardiac autonomic changes has not been 
extensively characterized. Vitamin D exerts its effects through a steroid nuclear receptor 
that(Holick 2007, Norman and Powell 2014) upon activation forms a complex with the 
retinoid X receptor.(Fetahu, Höbaus et al. 2014, Saccone, Asani et al. 2015) Activated 
vitamin D receptors (VDR) bind to vitamin D response elements (VDRE) on DNA and 
influence expression of a wide variety of genes covering numerous functions (ie. 
calcium homeostasis, antioxidant production, protein synthesis).(Sundar and Rahman 
2011, Fetahu, Höbaus et al. 2014, Norman and Powell 2014, Saccone, Asani et al. 
2015) For example, klotho is a membrane aging protein expressed in the sinoatrial node 
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region of the heart that is transcribed when vitamin D binds to VDRE. Decreased klotho 
has been demonstrated to be associated with shortened lifespan, vascular 
calcifications, arrhythmia as well as impaired vitamin D metabolism.(Song, Gao et al. 
2013) Given that vitamin D alters gene expression it is not entirely unreasonable to 
assume that it would contribute to cardiopulmonary dysfunction.  
Consequently, this is of interest to researchers given chronic VDD may cause 
subtle effects which increase the risk of a triggered adverse response to a stressor like 
air pollution. This is particularly true for complex, particulate matter (PM)-rich 
atmospheric photochemical smog, which is a mixture of not only PM but also ozone and 
other gaseous pollutants (e.g. acrolein and aldehyde isoforms) and represents the bulk 
of what people are exposed to in terms of ambient air pollution. It has long been 
demonstrated to be an environmental public health concern resulting in excess 
mortality.(Haagen-Smit 1952, Wilkins 1954, Lynne Page 1994) Therefore, the purpose 
of this study is to determine the effect of early-life persistent VDD in smog-induced 
cardiovascular toxicity. We hypothesized that low levels of vitamin D during early-life 
and persisting into adulthood would 1) induce electrical changes in the hearts of adult 
mice, 2) cause ventilatory alterations (i.e. altered breathing patterns), and 3) worsen the 
cardiopulmonary response to atmospheric smog. 
Materials and Methods 
Animals - Three-week old female C57Bl/6 mice (body weight = 9.6 ± 1.6g) were 
used in this study (Jackson Laboratory – Raleigh, NC). Mice were housed four-five per 
cage and maintained on a 12-hr light/dark cycle at approximately 22˚C and 50% relative 
humidity in an AAA-LAC-approved facility. Food (Prolab RMH 3000; PMI Nutrition 
International, St. Louis, MO) and water were provided ad libitum during the quarantine 
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period (3 days) after arrival. All protocols were approved by the Institutional Animal Care 
and Use Committee of the U.S. Environmental Protection Agency and are in 
accordance with the National Institutes of Health Guides for the Care and Use of 
Laboratory Animals. The animals were treated humanely and with regard for alleviation 
of suffering. 
Diet - Three days after the quarantine period ended, mice were maintained ad 
libitum on either a vitamin D deficient (VDD) (D10073001) or normal diet (ND) 
(D10012G-Research Diets Inc) for sixteen weeks. The VDD diet had no added vitamin 
D. The ND has 1000 IU per 10 grams of vitamin D. The diets had equal levels of all 
other vitamins and minerals including calcium, which was at the concentration specified 
by the American Institute of Nutrition.(Reeves, Nielsen et al. 1993) Water was provided 
ad libitum throughout the diet regimen.  
Experimental Design and Groups – At the beginning of the study, mice were 
randomly assigned into a ND (n = 28) or VDD (n = 35) group and maintained on those 
diets for the extent of the study. Of those animals, 12 of the ND and 12 of the VDD mice 
were randomly chosen and implanted with radiotelemeters at 16 weeks of age. Each of 
the ND and VDD animal groups with radiotelemeters were then further randomly 
assigned to air (FA) or smog exposure groups as were the non-telemetered ND and 




Figure 2-1. Experimental design of diet regimen, electrocardiographic/HRV 
analysis and photochemical smog exposure. 
 
Surgical Implantation of radiotelemeters and data acquisition – Animals were 
implanted with radiotelemeters and monitored as previously described(Kurhanewicz, 
McIntosh-Kastrinsky et al. 2014). Briefly, animals were anesthetized using inhaled 
isoflurane (Butler Animal Health Supply, Dublin OH) and using aseptic technique, each 
animal was implanted subcutaneously with a radiotelemeter (ETA-F10, Data Sciences 
International, St Paul, MN) to approximate the lead II of a standard electrocardiogram 
(ECG). All animals were allowed 7-10 days to recover from the surgery and reestablish 
circadian rhythms. Signals from the radiotelemeters were used to monitor heart rate 
(HR), and ECG waveforms immediately following telemeter implantation, through 
exposure until 24hrs post-exposure. This methodology provided continuous monitoring 
and collection of physiologic data from individual mice. See Supplemental Information 
for specific details on radiotelemeter implantation, and HR and ECG analysis.  
Heart Rate Variability Analysis - Heart rate variability (HRV) was calculated as 
the mean of the differences between sequential RRs for the complete set of ECG 
waveforms using ECGAuto. For each 1-min stream of ECG waveforms, mean time 
between successive QRS complex peaks (RR interval), mean HR, and mean HRV-
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analysis–generated time-domain measures were acquired. The time-domain measures 
included standard deviation of the time between normal-to-normal beats (SDNN), and 
root mean squared of successive differences (RMSSD). HRV analysis was also 
conducted in the frequency domain using a Fast-Fourier transform. The spectral power 
obtained from this transformation represents the total harmonic variability for the 
frequency range being analyzed. In this study, the spectrum was divided into low-
frequency (LF) and high-frequency (HF) regions. The ratio of these two frequency 
domains (LF/HF) provides an estimate of the relative balance between sympathetic (LF) 
and vagal (HF) activity.  
Whole-Body Plethysmography - Ventilatory function (e.g. enhanced pause, tidal 
volume and minute ventilation) was assessed in awake, unrestrained mice using a 
whole-body plethysmograph (Buxco, Wilmington, NC). Assessments were performed at 
3, 8, 11 and 15weeks of age and 24hrs prior to the day of exposure, immediately post-
exposure and 24hrs after exposure. The plethysmograph pressure was monitored using 
Biosystems XA software (Buxco Electronics Inc., Wilmington, NC). Using respiratory-
induced fluctuations in ambient pressure, ventilatory parameters including tidal volume 
(VT), breathing frequency (f), inspiratory time (Ti), expiratory time (Te), minute volume 
(MV) and enhanced pause (Penh), which is a measure of ventilatory timing and can 
indicate airway irritation, were calculated and recorded on a breath-by-breath basis. 
Tissue Collection and Analysis - Mice were euthanized 24 hours after exposure 
and blood and bronchoalveolar lavage fluid (BAL) were collected, processed and 
analyzed. Multiple biochemical markers (e.g. lactate dehydrogenase, protein, etc) were 
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assessed in the BAL. Vitamin D concentrations were determined in the serum spectro-
photometrically using a Vitamin D EIA Kit (Cayman Chemical, Ann Arbor, Michigan). 
Photochemical Smog Exposures – A PM-enriched atmosphere with high 
particulate matter and low ozone and nitrogen oxide concentrations (PM-enriched) was 
generated in the Mobile Reaction Chamber (MRC) as described in detail by Krug et al. 
(Krug 2018)Briefly, PM-enriched atmosphere was artificially generated with 0.491 ppm 
nitrogen oxide, 0.528 ppm NOx, 29.9 ppmC total hydrocarbons (THC), 24 ppmC 
gasoline and 5.3 ppmC α -pinene as the initial conditions, which were then irradiated by 
ultraviolent light. PM-enriched smog atmosphere was transported under vacuum to 0.3 
m-3 whole body inhalation chambers. Continuous gas and aerosol sampling for carbon 
monoxide, ozone, nitrogen oxides, THC and particle mass concentration were 
conducted at both the MRC unit as well as from the inhalation exposure systems. All 
PM was formed as secondary organic aerosol from the photochemical reactions in the 
MRC. Particle size distributions and gravimetric mass sampling was measured. Filter 
sampling for gravimetric analysis were conducted for the entire exposure time. Volatile 
organic compound (VOC) summa cannisters were periodically collected and analyzed 
by gas chromatography off-line to determine concentrations of various VOCs in the 
exposure atmosphere.   
Statistics - All data were analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC) 
software. Mixed-model ANOVAs, with Tukey’s procedure for the post hoc comparisons, 
were used to examine the statistical differences between exposure and diet. To improve 
normality of the residuals and because the HRV variable distributions were highly 
skewed, each HRV parameter was natural- log transformed. Also, the delta values of 
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the variables from baseline were used in this analysis. The statistical significance was 
set at P < 0.05. 
Results 
Exposure characteristics - The measured criteria pollutants in PM-enriched 
atmosphere (MR044) were ozone (0.094 ppm), NOx (0.154 ppb) and PM2.5 (0.307 
mg/m3). The ten most abundant secondary compounds that were generated in the 
atmosphere were: ethanol (1.03 ppm), alpha-pinene (0.533 ppm), toluene (0.463 ppm), 
2-methylpentane (0.330 ppm), n-hexane (0.222 ppm), isopentane (0.212 ppm), m-& p-
xylene (0.201 ppm), 3-methylpentane (0.187 ppm), n-pentane (0.103 ppm) and n-
butane (0.0748 ppm) (Figure 2-2) The Air Quality Health Index (AQHI), which provides a 
health-risk assessment of the smog, was 34.3. (Krug 2018) 
 





Body weight and vitamin D levels - Body weight was determined on a weekly 
basis; there were no differences between ND and VDD mice (Figure 2-3). Vitamin D 
levels were confirmed to be lower in all VDD mice (1.06 ± 0.1 ng/mL) when compared to 
ND mice (21.1±2.2 ng/mL).  
 
Figure 2-3. Body weight did not differ and VDD mice did become VDD during diet 
regimen. A. No significant differences in body weight. n = 28-35 B. VDD mice had 
significantly less serum vitamin D levels than ND mice. *significantly different from ND 
(p < 0.05). Values represent means ± SE. 
 
Heart rate and heart rate variability – HR was decreased in VDD mice from the 
time of telemeter implantation up until exposure (Figure 2-4A), while HRV (SDNN, 
RMSSD, HF) increased during the same time period (Figure 2-4 B-D). Log-normal 
distribution was calculated for HRV because the data was not normally distributed. HR 
decreased significantly 24 hours after air exposure in ND animals and after PM-
enriched exposure in VDD animals. ND animals exposed to PM-enriched smog and 
VDD animals exposed to air did not exhibit any changes (i.e. their HR did not decrease 
after exposure) (Figure 2-5A). SDNN was increased in all groups both immediately and 
24 hours after exposure when compared to pre-exposure, yet it only decreased in the 
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24hrs after exposure in ND mice exposed to PM-enriched smog. VDD increased SDNN 
irrespective of the exposure, yet when combined, VDD and PM-enriched smog had a 
significantly greater effect on SDNN than either alone (Figure 2-5B). Similar trends were 
observed with RMSSD in which the combination of VDD and PM-enriched smog had a 
greater effect than either VDD or PM-enriched alone (Figure 2-5C). HF, which is the 
time frequency domain measure of HRV, decreased significantly due to VDD and PM-
enriched exposure (Figure 2-5D); interestingly, this phenomenon was also observed in 
ND mice exposed to air but not in VDD mice exposed to air or the ND mice exposed to 
PM-enriched exposure. No significant changes were observed in LF (data not shown).  
 
Figure 2-4. VDD mice had decreased heart rate and increased HRV prior to 
exposure. (A.) Heart rate was significantly decreased in VDD mice when compared to 
ND, whereas SDNN (B.), RMSSD (C.), and HF (D.) were significantly increased. 
Parameters were analyzed from the time of radiotelemeter implantation until exposure. * 





Figure 2-5. VDD alters heart rate and heart rate variability after PM-enriched 
exposure. There were no changes in HR or HRV immediately after exposure in both 
ND and VDD mice (A - D). SDNN was increased in all groups 24hrs after exposure 
when compared to pre-exposure except ND mice exposed to PM-enriched. VDD 
increased SDNN irrespective of the exposure, yet when combined, VDD and PM-
enriched exposure had a significantly greater effect on SDNN than either alone (B.). 
Similar trends were observed with RMSSD for which the combination of VDD and PM-
enriched smog had a greater effect than either VDD or PM-enriched exposure alone 
(C.). HF decreased significantly in VDD mice exposed to PM-enriched smog and ND 
mice exposed to FA but not in VDD mice exposed to FA or ND mice exposed to PM-
enriched exposure (D.) *significantly different from ND (p < 0.05).  ◊significantly different 
from pre-exposure (p < 0.05).  † significantly different from immediately post-exposure. ‡ 
significantly different from filtered air exposure. Values represent means ± SE. 
 
During exposure, HR decreased from baseline (30-minute acclimation period 
before exposure) in all animals regardless of diet or exposure. PM-enriched smog 
significantly blunted the decrease in HR in ND mice; a similar effect was seen in VDD 
mice but to a lesser degree (Figure 2-6A). SDNN increased in VDD mice during air 
exposure and in ND mice during smog exposure however there was no effect in VDD 
mice exposed to PM-enriched smog (Figure 2-6B). In addition, RMSSD increased 
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significantly in VDD mice during air exposure when compared to ND; this response was 
further increased if the animals were exposed to PM-enriched smog (Figure 2-6C). HF 
only increased in VDD mice during PM-enriched exposure (Figure 2-6D). No significant 
changes were observed in LF parameter during exposure (data not shown). Lastly, the 
number of arrhythmias significantly increased in ND mice during PM-enriched exposure 
and although VDD appears to also increase total arrhythmias the results were not 
significant (Figure 2-6E).  
 
Figure 2-6. Exposure to PM-enriched smog prevents the recovery of resting heart 
rate in normal and VDD mice but only potentiates parasympathetic modulation in 
the latter. (A.) PM-enriched exposure significantly blunted the decrease in HR in both 
ND and VDD mice. (B.) SDNN increased in VDD mice during FA and in ND mice during 
PM-enriched exposure, however there was no effect in VDD mice exposed to PM-
enriched smog. (C.) RMSSD increased significantly in VDD mice during FA when 
compared to ND; this response was further increased with PM-enriched smog. (D.) VDD 
mice exposed to PM-enriched smog had significantly increased HF when compared to 
ND and VDD mice exposed to FA. (E.) VDD mice exposed to air had significantly 
increased arrhythmia when compared to PM-enriched smog, but there was no effect of 
PM-enriched smog in VDD mice. * significantly different from ND (p < 0.05). 
‡significantly different from filtered air exposure (p < 0.05). Values represent means ± 
SE.  
 
Ventilatory function – Table 2-1, Table 2-2 and Figure 2-7 show the ventilatory 
data. Although the mice randomly placed on the ND had a lower f at 3 weeks of age 
47 
 
than those placed on the VDD the f was comparable at 8 weeks of age and continued to 
decrease with age for both groups (Figure 2-7A). Similarly, although VT/MV were higher 
in the VDD group at the beginning of the diet regimen and up to 8 weeks of age, further 
increases in VT/MV over time were blunted in the VDD mice when compared to ND mice 
(Figure 2-7B – VDD -72.4% increase; ND - 111.2% increase at 15wks). VDD mice had 
decreased Ti before and through the diet regimen when compared to ND mice while 






















ND 3 474.2±0.6 0.13±0.0 51.69±0.1 83.46±0.1 6.42±0.0  





























432.8±0.6 0.29±0.0 61.97±0.1 81.69±0.2 12.37±0.0 1.26±0.0 
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435.5±0.6 0.3±0.0 61.75±0.1 81.98±0.2 12.24±0.0 1.54±0.0 
 
Table 2-1. VDD induced changes in ventilatory function parameters during diet 
regimen. * significantly different from 3-week assessment (p < 0.05).◊ significantly 





Figure 2-7. VDD mice have impaired development of normal breathing patterns 
and higher breathing frequency during PM-enriched exposure. VDD mice had 
significantly less decrease in f and increase in Vt during the 15 weeks of development 
when compared to ND (A. and B.). PM-enriched smog prevented f and penh from 
decreasing in both ND and VDD, but VDD mice had a significantly greater effect than 
ND (C. and D.). * significantly different from ND (p < 0.05). ¥ significantly different from 
3-week assessment (p < 0.05). ‡ significantly different from filtered air exposure (p < 
0.05).  Values represent means ± SE.  
 
Other than ventilatory timing (penh) being higher in VDD versus ND mice, there 
were no significant differences in the pre-exposure ventilatory parameters between the 
two diets (Table 2-2). All subsequent comparisons for exposure-related ventilatory 
effects were made within group. As such, all animals experienced a significant decrease 
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in f after exposure; however, this decrease enriched (i.e. f decreased the least in VDD 
mice after PM-enriched). Similar trends were observed with VT, Ti, and Te however the 
values increased after exposure. Penh increased after PM-enriched exposure in ND 
mice when compared to pre-exposure and with respect to their controls; all the other 
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Table 2-2. Ventilatory function of ND and VDD mice is altered after photochemical 
smog exposure. * significantly different from ND (p < 0.05). ◊ significantly different from 
pre-exposure (p < 0.05). ‡ significantly different from filtered air exposure (p < 0.05). 





Electrocardiogram analysis – The data is presented in Table 2-3. There were no 
significant differences in any parameters during the pre-exposure period. The PR 
interval decreased significantly from baseline during air exposure in both ND and VDD 
animals but there were no differences between the diets during, immediately and 24hrs 
after exposure. In contrast, the PR interval of VDD mice was increased compared to ND 
mice during PM-enriched exposure, immediately after and 24hrs later. PM-enriched 
exposure caused a decreased PR interval in ND mice and increased PR interval in VDD 
mice when compared to their respective air-exposed controls. VDD animals had a 
decreased QRS interval during air exposure when compared to ND; this difference 
between VDD and ND was also observed in animals exposed to PM-enriched and 
persisted 24hrs after that exposure. Smog exposure also caused a significant decrease 
in QRS complex in ND mice when compared to controls. Lastly, VDD caused a 
decrease in QTc when compared to ND with either air or PM-enriched exposure during 
either exposure or immediately after but there were no significant differences among 









Diet Exposure Timing PR (ms) QRS (ms) QTcB (ms) 
ND Filtered 
Air 
Pre-Exposure 37.21±0.28 10.38±0.11 56.23±0.65 
Exposure 36.62±0.10 § 7.66±0.14 57.16±0.55 
Immediately 
Post-Exposure 
37.42±0.22 10.85±0.09 59.24±0.67 
24 Hr Post-
Exposure 
37.58±0.23 10.55±0.06 55.16±0.68 
Smog Pre-Exposure 37.22±0.34 10.40±0.08 56.21±0.80 
Exposure 36.07±0.08 ‡ 6.43±0.15 ‡ 56.53±0.47 
Immediately 
Post-Exposure 
36.27±0.30 ‡ 10.60±0.07 54.82±0.79 ‡ 
24 Hr Post-
Exposure 
36.06±0.25 ‡ 10.34±0.06 55.11±0.86 
VDD Filtered 
Air 
Pre-Exposure 37.27±0.45 10.39±0.10 55.20±0.71 
Exposure 36.49±0.10 § 6.31±0.14 §* 54.96±0.56 
Immediately 
Post-Exposure 
36.49±0.24 * 10.40±0.08 * 54.82±0.44 * 
24 Hr Post-
Exposure 
36.31±0.21 * 10.42±0.09  55.02±0.57 
Smog Pre-Exposure 37.34±0.22 10.38±0.10 56.37±0.46 
Exposure 37.46±0.08 ‡* 5.35±0.14 * 54.13±0.47 * 
Immediately 
Post-Exposure 
38.11±0.23 ‡* 10.46±0.08 54.63±0.41 
24 Hr Post-
Exposure 
37.15±0.20 ‡* 10.01±0.06 ‡* 53.37±0.46 
 
Table 2-3. Smog exposure and VDD induced alterations in electrocardiographic 
morphology in adult mice. * significantly different from ND (p < 0.05). † significantly 
different from immediately-post exposure (p < 0.05).◊ significantly different from pre-
exposure (p < 0.05). ‡ significantly different from filtered air exposure (p < 0.05). § 










This study demonstrates that early life and persistent vitamin D deficiency into 
adulthood modifies the cardiopulmonary response to PM-enriched smog exposure. 
These results add to a growing body of research which shows that the degree and 
quality of health effects of air pollution are not only governed by concentration and 
composition but also non-environmental factors. Some of these factors are directly 
related to the host and aspects of daily living which likely accrue intrinsic changes in the 
body over many years and alter the degree of responsiveness to an environmental 
challenge or the ability to compensate for one. Such might be the case with VDD, which 
has become a growing public health concern in the United States with some estimates 
of prevalence reaching 41.6%.(Forrest and Stuhldreher 2011) This is of particular 
concern because millions of children may be deficient (Kumar, Muntner et al. 2009) and 
remain so into adulthood thus increasing the likelihood of chronic diseases. Although it 
has not been studied as extensively as bone-related maladies, the cardiopulmonary 
effects that result from VDD are increasingly being recognized as a cause, or promoter 
in the least, of several long-term diseases and heightened susceptibility to triggered 
adverse responses. Still this is the first study to show that VDD during development and 
into adulthood alters and potentially worsens the response to air pollution in mice.  
Traditional toxicological investigations, particularly in rodents, have been using 
susceptible models (e.g. hypertension, metabolic syndrome, etc) to further characterize 
the risk of adverse responses to air pollution. Our own studies indicate that rodent 
strains with underlying cardiovascular disease have a worse response (e.g. arrhythmia) 
to air pollution than normal strains although the effects are often latent and can only be 
observed when a subsequent challenge or trigger is used to manifest them. (Hazari, 
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Haykal-Coates et al. 2009, Farraj, Hazari et al. 2011, Hazari, Haykal-Coates et al. 2011, 
Hazari, Callaway et al. 2012, Carll, Lust et al. 2013, Hazari, Griggs et al. 2014) This 
suggests that to some degree the adverse effects of air pollution may be due more to 
disruption of homeostasis than direct tissue toxicity. Imbalance in autonomic control of 
the cardiovascular system as measured by heart rate variability is an example of such 
changes and has been well documented not only in rodents but in humans as well. 
(Binkley, Nunziata et al. 1991, Liao, Creason et al. 1999, Brook and Julius 2000) 
Furthermore, the importance of such an assessment rests in the fact that it indicates a 
subtle shift in the underlying regulation of the body’s dynamic systems which may not 
be manifested as clinical symptoms or overt signs of toxicity. Thus, the objective of this 
study was to investigate whether VDD acts as a modifiable factor in smog-induced 
cardiopulmonary dysfunction. We hypothesized that as a result of early-life VDD the 
homeostatic balance of the cardiopulmonary system would be altered, thus the 
cardiopulmonary response to stressors like smog would also change. 
Although the VDD mice were maintained on the deficient diet immediately post-
weaning there was no difference in the body weights or the growth of VDD animals after 
15 weeks as determined by tibia length (not shown) when compared to ND. Even 
calcium levels were found to be in the normal range for all mice irrespective of diet. 
Despite this seemingly normal development, VDD deficient mice had increased heart 
rate variability, indicating altered cardiac autonomic function, when compared to 
controls in the two weeks prior to exposure. Although decreased HRV is generally 
thought of as the primary indicator of cardiac risk (Gold, Litonjua et al. 2000, Pope, 
Hansen et al. 2004), an increase in HRV may not necessarily be a positive sign. (Stein, 
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Domitrovich et al. 2005) Instead, it may be the change from normal which suggests an 
impaired regulation of the cardiovascular system but in a way that may not be entirely 
appreciated until the body is challenged and has to maintain homeostasis. Increases in 
vagal tone or HRV have been associated with adverse cardiovascular events in 
diabetes (Eguchi, Schwartz et al. 2010), and linked with increased mortality in heart 
failure patients and the elderly. (de Bruyne, Kors et al. 1999, Stein, Domitrovich et al. 
2005)  In addition, increased RMSSD has been found to be associated with elevated 
risk of air pollution-induced arrhythmia. (Davoodi, Sharif et al. 2010)  
An increase in HRV suggests parasympathetic modulation of the cardiovascular 
system which was clearly seen as a significantly lower heart rate in the VDD animals 
when compared to ND. Vitamin D deficiency is linked to HRV changes in humans as 
well (Canpolat, Özcan et al. 2015, Jung, Jung et al. 2015, Mann, Hollenberg et al. 2015) 
and although the profile differs from rodents the overall conclusion that subtle 
underlying alterations are occurring in the deficient state holds true. It is likely the 
differences between humans and mice may be due to the fact that in contrast to 
humans, baseline heart rate in mice is influenced greatly by the sympathetic branch 
(Just, Faulhaber et al. 2000) and short-term HRV is under the control of 
parasympathetic modulation. (Gehrmann, Hammer et al. 2000, Pham, Bonham et al. 
2009) Furthermore, the HRV effects of VDD in humans may be due to other disease 
processes (e.g. kidney disease) related to chronic deficiency which is still not confirmed 
to occur in mice. It may be that mice develop a similar HRV decrement if left on the 
deficient diet for a longer period; our future studies will address this issue. In any case, it 
is not entirely clear why VDD causes altered autonomic function in mice. One study 
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showed that VDD caused changes in calcium flux and cardiomyocyte contraction-
relaxation, which was shown to be linked to vitamin D receptors (VDR) located on the T-
tubule (Tishkoff, Nibbelink et al. 2008); the authors concluded that these effects would 
likely result in changes in heart rate. On the other hand, 24hrs before exposure there 
was still a trend of increased HRV (SDNN and RMSSD) in the VDD animals when 
compared to ND even though the HR among the groups was similar. This suggests that 
other factors may have contributed to the changes in HRV; in fact, VDD has been 
shown to affect blood pressure, which is a known determinant of HRV. (Artaza, 
Mehrotra et al. 2009) 
We have consistently shown that heart rate tends to decrease gradually over a 3-
4 hour air exposure as the animal calms down in the chamber. In the presence of air 
pollution, heart rate does not decrease as much (i.e. remains elevated). (Carll, Lust et 
al. 2013, Farraj, Walsh et al. 2015) In the current study, although PM-enriched smog 
prevented HR from decreasing in both ND and VDD groups, the effect was significantly 
less in the VDD mice (i.e. HR of VDD mice was less elevated), which along with the 
greater increase in RMSSD and HF appears to confirm the shift towards 
parasympathetic modulation in the VDD animals. This modulation was also reflected in 
the greater decrease in HR and increase in RMSSD in VDD animals exposed to air. 
These trends persisted immediately after exposure with HR continuing to decrease over 
the next 24hrs. Over the same period SDNN and RMSSD continually increased in all 
groups except ND animals exposed to PM-enriched smog, which consequently had the 
smallest decrease in HR. It is unclear whether this relatively smaller decrease in HR 
and increase in HRV in the ND mice exposed to PM-enriched reflects increased risk. 
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(Tsuji, Larson et al. 1996, La Rovere, Pinna et al. 2001) These responses are similar to 
what was observed and reported for PM-enriched by Hazari et al. in this issue with the 
difference in effects due to VDD being evident here. (Hazari and Stratford 2018) Indeed, 
this group had a significantly increased number of arrhythmia during exposure but these 
stopped after it ended. Similar increases in arrhythmia incidence were observed in the 
other three treated groups, especially VDD mice exposed to air which had a large 
number of atrial premature beats, but they were not significant. Yet, there is some 
indication from past studies that VDD is associated with arrhythmia (Ozcan, Gurlek et 
al. 2015) due to a number of mechanisms, either by activation of the RAAS axis and 
predisposition to hypertension (Lee, O'Keefe et al. 2008), through the enhancement of 
myocardial oxidative stress (Argacha, Egrise et al. 2011, Gradinaru, Borsa et al. 2013), 
or by increasing PTH levels which also affects blood pressure and myocardial 
contractility (Ogard, Sondergaard et al. 2005, Zittermann 2006). Whether these 
conditions existed in our animals is unknown and further does it worsen the response to 
air pollution likely remains to be clarified.  
Assessments of ventilatory function were also performed from the beginning of 
the diet regimen to the end of the study and revealed some diet-induced effects. 
Although the animals were randomly assigned to either the normal or deficient diet, the 
VDD group had a higher breathing frequency than ND before commencing the diets. 
This difference did not exist at 15 weeks of age. In contrast, VDD animals had a 
significantly reduced increase in tidal volume over the 16 week diet regimen when 
compared to ND. Numerous studies have documented the negative effects of VDD on 
lung development in both humans and rodents. (Zosky, Hart et al. 2014, Foong, Bosco 
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et al. 2015, Chen, Wilson et al. 2016) Furthermore, it appears that VDD causes deficits 
in lung function that are primarily explained by differences in lung volume and also 
exacerbates the development of lung COPD-like characteristics (i.e. inflammation) in 
mice exposed to cigarette smoke. Two important points are relevant here given these 
conditions; first, it is clear that the dose of PM-enriched smog in VDD animals may have 
been different from ND animals, and second, it is likely the airway responsiveness of 
VDD mice to PM-enriched smog was also changed. We cannot address the first point 
since we were unable to measure ventilatory function during exposure. However, when 
compared to pre-exposure, VDD animals had a significantly smaller decrease in 
breathing frequency after exposure than ND and this effect was even greater when VDD 
and PM-enriched smog were combined. A similar trend was observed in ventilatory 
timing (penh), which is an indicator of airway irritation, suggesting VDD may have 
altered the ventilatory responses to the smog. This is relevant to the overall hypothesis 
of this study because ventilatory patterns not only affect HRV but also can play a role in 
adverse cardiac events (e.g. arrhythmia) when triggered by airway irritation. 
(Widdicombe and Lee 2001)  
Finally, there were some notable changes in ECG parameters in this study. 
Although there were no pre-exposure differences in any of the ECG parameters 
between any of the groups, PM-enriched exposure caused a significant increase in PR 
interval and decrease in QRS complex duration when compared to air; this smog effect 
was altered by VDD and persisted for 24hrs after exposure only in that group. Even 
though these changes may just represent fluctuations in the heart rate and not any true 
electrical disturbances or pathology there is a clear impact of VDD by which the PM-
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enriched-induced effect continued into the next day. In such a situation, if these ECG 
changes truly were due to an electrical disturbance then it would not be inconceivable 
for a subsequent adverse cardiac event to be triggered, even if hours after the exposure 
had ended. In addition, our animals were only kept on the diet for 16 weeks, which may 
not have been enough time for VDD to cause more tangible effects. For example, 
chronic changes in blood pressure are connected with vitamin D levels but this was not 
evaluated in this study. Thus, future experiments will be conducted on animals that are 
kept on VDD for more than 32 weeks and will include other physiological measures that 
will help to potentially clarify the ECG phenomenon.  
Conclusions 
In conclusion, persistent VDD that begins in early-life alters HR, HRV and 
ventilatory parameters and changes the response to smog. In particular, the changes in 
HRV or autonomic imbalance that were observed may represent altered homeostasis, 
which potentially suggests that the body is prone to an adverse response if an 
environmental trigger or stressor is encountered. Although this has yet to be proven, our 
previous studies clearly show that autonomic imbalance plays a role in triggered cardiac 
dysfunction. This study is relevant because it demonstrates how nutritional deficiencies 
can subtly modify the homeostatic balance of the cardiopulmonary system and increase 
risk from exposure to PM-enriched smog. This especially applies to children who are 
VDD and may be at heightened risk of developing cardiovascular disease later in life 
and so may also be particularly sensitive to the effects of air pollution. Regardless, if 
present in man such effect modification could have significant relevance to public health 
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Chapter 3: The Effects of Klotho on Acrolein-Induced Heart rate and Heart Rate 
Variability Changes in Normal and Vitamin D Deficient Mice 
Introduction 
Cardiovascular morbidity and mortality are strongly correlated with short and long 
term ambient air pollution exposure,(Brook, Rajagopalan et al. 2010) which at times 
only manifests as subtle or latent changes especially in healthy individuals. These 
changes include autonomic imbalance or electrical disturbances (i.e. arrhythmia) which 
are indicative of increased cardiovascular risk even after acute exposure. Furthermore, 
research within the last ten years has shown that there are several factors that 
contribute to this effect. These include not only factors related to air pollution such as 
concentration, composition and chemistry, but also intrinsic host factors like nutrition. As 
far as the latter is concerned, homeostatic regulation and proper cardiac function is 
dependent on adequate levels of micronutrients. Vitamin D is one of the micronutrients 
needed by the body with a critical homeostatic role in several organ systems including 
the cardiovascular system.(Holick 2007, Lee, O'Keefe et al. 2008) Additionally, vitamin 
D receptors are present on numerous tissues and cells throughout the body, including 
cardiomyocytes.(Holick 2007)  
Unfortunately, vitamin D deficiency (VDD) has become highly prevalent in the 
United States, as well as in the world, even affecting otherwise healthy individuals but 
there is not a consensus regarding the threshold of VDD. (Gordon, DePeter et al. 2004, 
Holick 2007, Martins, Wolf et al. 2007, Gordon, Feldman et al. 2008, Bener, Al-Ali et al. 
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2009, Kumar, Muntner et al. 2009) Although, VDD has been traditionally studied with 
respect to calcium regulation and bone-related conditions, it is now known that it also 
contributes to adverse cardiovascular outcomes.(Holick 2007, Mann, Exner et al. 2013, 
Masson, Agabiti et al. 2014)  For example, during early-life or childhood, VDD can lead 
to vascular dysfunction and subsequent hypertension.(Gordon, Feldman et al. 2008, 
Tare, Emmett et al. 2011, Weng, Sprague et al. 2013)  We previously showed that 
early-life persistent VDD induces autonomic imbalance in VDD mice that are otherwise 
healthy, similar findings have been demonstrated by others as well.(Canpolat, Özcan et 
al. 2015) (Stratford, 2018) Due to the fact that vitamin D is active throughout the body 
and elicits molecular and cellular effects in many different cell types, it is clear that VDD 
has the potential to induce numerous effects on the homeostatic controls of the body. 
Despite this understanding of VDD, a definitive mediator for these responses is still 
unknown. 
Therefore, these studies focused on the role of klotho, which is an anti-aging 
factor regulated by vitamin D and known to play a role in controlling intracellular 
signaling, oxidative stress and cation transport in various cell types.(Hazari, Haykal-
Coates et al. 2011, Ding and Ma 2015) In fact, klotho, which is upregulated with vitamin 
D receptor agonist supplementation,(Song, Gao et al. 2013)  is highly conserved 
between humans and mice.(Ding and Ma 2015) Klotho has a direct effect on the heart 
by maintaining sinoatrial function during stress and its deficiency has been linked to 
arrhythmia(Takeshita, Fujimori et al. 2004) and certain cardiovascular diseases.(Song, 
Gao et al. 2013) Hence, klotho might be a potential mediator of vitamin D effects in the 
body, particularly when a stressor like air pollution is encountered. 
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Ambient air pollution is a mixture of many particulate, gaseous and volatile 
compounds that are usually produced by combustion of fossil fuels. For example, 
acrolein is a ubiquitous air pollutant and a common product of combustion of diesel fuel, 
fatty foods, cigarette smoke, wood and other organic compounds into a gaseous 
unsaturated aldehyde.(Ghilarducci and Tjeerdema 1995, Kehrer and Biswal 2000) In 
humans and mice, acrolein is typically an upper airway irritant and the health effects are 
mostly limited to the nasal passages.(Kehrer and Biswal 2000) Regardless, acrolein 
inhalation is linked to a myriad of respiratory conditions including eye, nose and throat 
irritation,(Sim and Pattle 1957, Esterbauer, Schaur et al. 1991)  pulmonary 
edema(Kutzman, Popenoe et al. 1985, Hales, Barkin et al. 1989), bronchial hyper-
responsiveness(Ben-Jebria, Marthan et al. 1994, Bein and Leikauf 2011), respiratory 
distress(Ben-Jebria, Marthan et al. 1994, Bein and Leikauf 2011) and asthma 
exacerbations(Leikauf, Leming et al. 1989). In addition, animal and in-vitro studies have 
demonstrated that acrolein exposure results in adverse cardiovascular responses 
including cytotoxicity in vascular endothelial cells and cardiac fibroblasts(Toraason, 
Luken et al. 1989, Kachel and Martin 1994) as well as left ventricular hypertrophy, which 
can lead to dilated cardiomyopathy(Ismahil, Hamid et al. 2011). It has also been 
demonstrated to cause cardiac autonomic dysfunction and electrical instability.(Hazari, 
Haykal-Coates et al. 2009, Conklin, Haberzettl et al. 2017) 
However, the impact of VDD on these acrolein effects is unclear and warrants 
investigation, particularly because both vitamin D (Stratford, Haykal-Coates et al. 2018) 
and acrolein modulates autonomic function of the heart. Furthermore, vitamin D affects, 
potentially through klotho, the function of TRP channels, which are potently activated by 
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acrolein. Thus, the goal of this project was to determine how VDD modifies cardiac 
responses to acrolein in adult mice and clarify the role of klotho. We hypothesized that 
VDD-induced cardiopulmonary changes in acrolein responsiveness would be blocked 
by klotho. These studies seek to clarify whether treatment with klotho (potentially 
injectable) can mitigate the effects of VDD in this paradigm. 
Materials and Methods 
Animals - Three-week old female C57Bl/6 mice were used in this study (Jackson 
Laboratory, Raleigh, NC). Mice were housed five per cage and maintained on a 12-hr 
light/dark cycle at approximately 22˚C and 50% relative humidity in an AAA-LAC-
approved facility. Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, MO) 
and water were provided ad libitum during the quarantine period (3 days) after arrival. 
All protocols were approved by the Institutional Animal Care and Use Committee of the 
U.S. Environmental Protection Agency and are in accordance with the National 
Institutes of Health Guides for the Care and Use of Laboratory Animals. The animals 
were treated humanely and with regard for alleviation of suffering. 
Diet - Three days after the quarantine period ended, mice were maintained ad 
libitum on either a vitamin D deficient (VDD) (D10073001-Research Diets Inc.) or 
normal diet (ND) (D10012G-Research Diets Inc.) for nineteen or forty weeks. The VDD 
diet had no added vitamin D but had vitamin mix V10037. The ND has 1000 IU per 10 
grams of vitamin D which is the recommended amount for mice. The diets had equal 
levels of all other vitamins and minerals including calcium, which was at the 
concentration specified by the American Institute of Nutrition (Reeves, Nielsen et al. 
1993). Water was provided ad libitum throughout the diet regimen. 
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Experimental Design and Groups – At the beginning of the study, mice were 
randomly assigned into a ND (n = 20) or VDD (n = 20) group and maintained on those 
diets for the extent of the study. Of those animals, 18 of the ND and 18 of the VDD mice 
were randomly chosen and implanted with radiotelemeters at 20 weeks of age and 
given klotho. All mice were randomly assigned to filtered air (FA) or acrolein exposure 
groups. Figure 3-1 demonstrates the experimental design. 
 
Figure 3-1. Experimental Design. ND and VDD mice were put on their respective diets 
for 19 weeks. A subset of mice was implanted with radiotelemeters and then exposed to 
filtered air and then acrolein (3ppm) for 3 hours. In a follow-up study, mice were treated 
with klotho every other day for a month before the same telemeter implantation and 
exposure scheme.  
 
Surgical Implantation of Radiotelemeters - Animals were anesthetized using 
inhaled isoflurane (Isothesia, Butler Animal Health Supply, Dublin, OH). Anesthesia was 
induced by spontaneous breathing of 2.5% isoflurane in pure oxygen at a flow rate of 1 
L/min and then maintained by 1.5% isoflurane in pure oxygen at a flow rate of 0.5 L/min; 
all animals received the analgesic buprenorphrine (0.03 mg/kg, i.p. manufacturer). 
Briefly, using aseptic technique, each animal was implanted subcutaneously with a 
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radiotelemeter (ETA-F10, Data Sciences International, St Paul, MN); the transmitter 
was placed under the skin to the right of the midline on the dorsal side. The two 
electrode leads were then tunneled subcutaneously across the lateral dorsal sides; the 
distal portions were fixed in positions that approximated those of the lead II of a 
standard electrocardiogram (ECG). Body heat was maintained both during and 
immediately after the surgery. Animals were given food and water post-surgery and 
were housed individually. All animals were allowed 7-10 days to recover from the 
surgery and reestablish circadian rhythms.(Kurhanewicz, McIntosh-Kastrinsky et al. 
2014) 
Radiotelemetery Data Acquistion - Radiotelemetry methodology (Data Sciences 
International, Inc., St. Paul, MN) was used to track changes in cardiovascular function 
by monitoring heart rate (HR) and ECG waveforms immediately following telemeter 
implantation and through exposure until the end of exposure. This methodology 
provided continuous monitoring and collection of physiologic data from individual mice 
to a remote receiver. Sixty-second ECG segments were recorded every 15 minutes 
during the pre-exposure periods and continuously during exposure (baseline and hours 
1-3); HR was automatically obtained from the waveforms (Dataquest ART Software, 
version 3.01, Data Sciences International, St. Paul, MN). 
Electrocardiogram Analysis - ECGAuto software (EMKA Technologies USA, Falls 
Church, VA) was used to visualize individual ECG waveforms, analyze and quantify 
ECG segment durations and areas, as well as identify cardiac arrhythmias as previously 
described (Hazari, Haykal-Coates et al. 2009). Briefly, using ECGAuto, Pwave, QRS 
complex and T-wave were identified for individual ECG waveforms and compiled into a 
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library. Analysis of all experimental ECG waveforms was then based on established 
libraries. The following parameters were determined for each ECG waveform: PR 
interval (Pstart-R), QRS complex duration (Qstart-S), ST segment interval (S-Tend) and 
QT interval (Qstart-Tend). QT interval was corrected for HR using the correction formula 
for mice QTc = QT/(RR/100)1/2 (Mitchell, Jeron et al. 1998). Pre-exposure assessments 
were measured as the exposure time-matched four hours of data from 24 hours before 
exposure for each animal. 
Heart Rate Variability Analysis - Heart rate variability (HRV) was calculated as 
the mean of the differences between sequential RR intervals for the complete set of 
ECG waveforms using ECGAuto. For each 1-min stream of ECG waveforms, mean time 
between successive QRS complex peaks (RR interval), mean HR, and mean HRV-
analysis–generated time-domain measures were acquired. The time-domain measures 
included standard deviation of the time between normal-to-normal beats (SDNN), and 
root mean squared of successive differences (RMSSD). HRV analysis was also 
conducted in the frequency domain using a Fast-Fourier transform. The spectral power 
obtained from this transformation represents the total harmonic variability for the 
frequency range being analyzed. In this study, the spectrum was divided into low-
frequency (LF) and high-frequency (HF) regions. The ratio of these two frequency 
domains (LF/HF) provides an estimate of the relative balance between sympathetic (LF) 
and vagal (HF) activity. 
Whole-Body Plethysmography - Ventilatory function (e.g. enhanced pause, tidal 
volume and minute ventilation) was assessed in awake, unrestrained mice using a 
whole-body plethysmograph (Buxco, Wilmington, NC). Assessments were performed at 
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24 hours prior to the day of exposure and during exposure. The plethysmograph 
pressure was monitored using Biosystems XA software (Buxco Electronics Inc., 
Wilmington, NC). Using respiratory-induced fluctuations in ambient pressure, ventilatory 
parameters including tidal volume (VT), breathing frequency (f), inspiratory time (Ti), 
expiratory time (Te), minute volume (MV) and enhanced pause (Penh), which is a 
measure of ventilatory timing and can indicate airway irritation, were calculated and 
recorded on a breath-by-breath basis. 
Tissue Collection and Analysis - Mice were euthanized using euthasol 
euthanasia solution immediately after exposure and blood was collected, processed and 
analyzed. Vitamin D concentrations were previously determined (Stratford, Haykal-
Coates et al. 2018) and calicum and phosphorus were determined using (Sekisui 
Chemical, Japan). 
Klotho – Klotho protein (R&D systems, Minneapolis, MN). Mice were 
intraperitoneally treated with 1 mg/kg every other day for the 28 days just before mice 
were exposed to FA or acrolein for a total of 14 doses. Klotho mRNA was assessed 
using klotho Taqman primer for mouse (ThermoFisher, Waltham, MA) and a qPCR was 
performed (ThermoFisher, Waltham, MA). 
Acrolein Exposure – Acrolein exposures took place in whole-body 
plethysmography chambers (Model PLY3213, Buxco Electronics, Inc., Wilmington, NC). 
Acrolein gas was metered from a 1,000 ppm cylinder into a glass mixing chamber 
where the gas was mixed and diluted with dry filtered air to achieve a final concentration 
of 3 ppm of acrolein with a total flow of 6 L/min. The actual chamber concentration was 
measured once per hour using an HP5890 gas chromatograph (GMI Inc., Ramsey, MN) 
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equipped with manual injection, a flame ionization detector and a DB-VRX capillary 
column. 
Statistics - All data were analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC) 
software. Mixed-model ANOVAs followed by Tukey’s procedure for the post hoc 
comparisons were used to examine the statistical differences between exposure and 
diet. The statistical significance was set at P < 0.05. 
Results 
Klotho mRNA expression and serum calcium/phosphate levels – Klotho mRNA 
expression in the hearts of VDD mice was decreased compared to ND mice (Figure 3-
2A). However, serum calcium (Figure 3-2B) and phosphate (Figure 3-2C) levels were 
not different between the diets. 
 
Figure 3-2. Klotho mRNA in the heart and serum calcium and phosphate levels. 
(A.) Klotho mRNA expression in the heart was significantly decreased in VDD mice. (B.) 
Serum calcium levels were not different between the diets. (C.) Serum phosphate levels 
were not different between the diets. *significantly different from ND (p < 0.05). Values 
represent means ± SEM. N=5-6 
 
Heart rate and arrhythmias – Heart rate was measured before and during both 
filtered air and acrolein exposures. Heart rate was increased in VDD compared to ND 
mice pre-exposure and klotho blocked the response (Figure 3-3A). Acrolein exposure 
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increased HR in both ND and VDD mice, but during the first and third hours of 
exposure, VDD mice had significantly decreased HR compared to ND mice. There was 
no difference between the diets during the second hour of exposure. However, with 
klotho administration blocked the HR changes during exposure for both ND and VDD 
mice (Figure 3-3B). The number of arrhythmias observed in ND and VDD mice during 
FA exposure was similar to the first hour of acrolein exposure. Arrhythmias significantly 
increased during the third hour of acrolein exposure for both ND and VDD mice. Klotho 
further increased arrhythmias during the second and third hours of acrolein exposure in 








Figure 3-3. Klotho blocks acrolein-induced heart rate changes but worsens 
arrhythmias.  (A.) VDD mice had higher baseline HR when compared to ND; although 
HR was higher for both diet groups with klotho, the difference between them was 
blocked by klotho. (B.) Acrolein increased HR in ND and VDD mice, however, HR was 
significantly less in the latter during the 1st and 3rd hours of exposure. The HR 
responses of both ND and VDD were completely blocked by klotho. (C.) There were no 
arrhythmias during FA or during the 1st and 2nd hours of acrolein exposure, however, 
arrhythmias increased during the 3rd hour of acrolein for both diet groups and klotho 
worsened the response. *significantly different from ND (p < 0.05). ◊significantly different 
from diet without klotho (p < 0.05). Values represent means ± SEM. N=7-9 
 
Heart rate variability – Heart rate variability was measured before and during the 
FA and acrolein exposures. Prior to the exposures, VDD mice had significantly 
decreased SDNN and RMSSD when compared to ND, klotho decreased both SDNN 
and RMSSD in both diet groups but also blocked the differences between them (Figure 
3-4A & B). The LF and HD showed a decreased trend in VDD mice (p=.055) when 
compared to ND before exposure, klotho significantly decreased these responses in 
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both diet groups (Figure 3-4C & D). 
 
Figure 3-4. Klotho decreases baseline HRV. (A.) SDNN and RMSSD were 
significantly decreased in VDD mice during pre-exposure; although treatment with 
klotho decreased both parameters in both diet groups, it also blocked the differences 
between them (A. and B.) LF and HF were not different between the diet groups pre-
exposure but klotho administration significantly decreased both in ND and VDD mice. 
(C. and D.) *significantly different from ND (p < 0.05). ◊ significantly different diet without 
klotho administration (p < 0.05). Values represent means ± SEM. N=7-9 
 
Acrolein caused SDNN, RMSSD, LF and HF to increase during the second and 
third hours of exposure in both diet groups. However, overall cardiac autonomic function 
was significantly decreased in VDD mice compared to ND during that time period 
(Figure 3-5 A-D). Treatment with klotho increased virtually all of the HRV parameters 
during the 2nd hour of acrolein exposure in both diet groups. In contrast, klotho 
decreased all HRV parameters during the third hour of acrolein exposure in ND and 
VDD mice (Figure 3-5 A-D). Overall, treatment with klotho appeared to stabilize HRV 
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and prevent the drastic change normally observed with acrolein exposure, particularly 
the increase during the 3rd hour.(Kurhanewicz, McIntosh-Kastrinsky et al. 2017)  
 
Figure 3-5. Acrolein-induced changes in HRV are modulated by klotho. Acrolein 
increased SDNN, RMSSD, LF and HF in ND and VDD mice, however, the parameters 
were significantly less for the latter during the 2nd and 3rd hours. Klotho increased these 
parameters during the 2nd hour but prevented them from increasing in the 3rd hour for 
both diets (A. – D.). *significantly different from ND (p < 0.05). ◊significantly different 
from diet without klotho (p < 0.05). Values represent means ± SEM. N=7-9 
 
Ventilatory function – Ventilatory function was assessed before and during the 
FA and acrolein exposures. During air exposure, breathing frequency was only different 
between ND and VDD mice during the first hour while klotho further increased the 
response (Figure 3-6A). ). Ventilatory timing was not different between ND and VDD 
mice during air exposure, however, klotho decreased it during the second and third 
hours for both diets (Figure 3-6B). Compared to FA, breathing frequency slightly 
decreased during acrolein exposure with ND mice having increased breathing 
frequency only during the second hour of exposure compared to VDD mice. Klotho 
significantly decreased breathing frequency with acrolein exposure especially during 
exposure compared to FA exposure (Figure 3-6C). Acrolein significantly increased 
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ventilatory timing compared to FA in both ND and VDD mice, this was significantly 
higher in VDD mice treated with klotho during the first hour. Klotho increased ventilatory 
timing in ND mice with acrolein exposure. (Figure 3-6D).  
 
Figure 3-6. VDD-induced ventilatory function changes are modified by klotho 
during both air and acrolein exposure. (A.) During air exposure, breathing frequency 
was only different between ND and VDD mice during the first hour and klotho further 
increased the response. (B.) During air exposure, ventilatory timing was the same for 
ND and VDD mice; klotho decreased the response in both diet groups. (C.) Acrolein 
caused an initial decrease in breathing frequency in all groups. Although both ND and 
VDD animals increased their breathing rate thereafter, the latter had a greater increase. 
On the other hand, klotho significantly decreased breathing frequency in both diet 
groups. (D.) All animals experienced an increase in ventilatory timing during acrolein 
exposure and klotho administration further increased ventilatory timing in ND and VDD 
mice. *significantly different from ND (p < 0.05). ◊ significantly different from diet without 
klotho (p < 0.05). N=9  
 
Discussion 
This study demonstrates that VDD modifies the cardiopulmonary response of 
mice to acrolein and although klotho appears to block these effects of VDD, it also alters 
the cardiac function and response of ND mice. Basing the approach of this study on 
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commonly-accepted pharmacological principles, it was hypothesized that treatment with 
klotho would block the acrolein response only in deficient animals. This was due to 
klotho’s low levels in VDD mice and primarily due to the fact that many of the effects of 
vitamin D are mediated by klotho.(Chen, Kuro et al. 2013, Berridge 2015, Navarro-
Garcia, Fernandez-Velasco et al. 2018) We previously showed that acrolein has potent 
effects on the autonomic nervous system as indicated by HRV (Kurhanewicz, McIntosh-
Kastrinsky et al. 2017) and we assumed that not only would vitamin D modify these 
effects but that klotho would block those effects much like a pharmacological drug. 
Vitamin D deficiency is known to cause potentially detrimental changes to the 
homeostatic mechanisms of the body, including autonomic imbalance, and it is believed 
that the effects may be due to a decrease in klotho.(Forman, Curhan et al. 2008, Weng, 
Sprague et al. 2013, Canpolat, Özcan et al. 2015, Chen, Sun et al. 2015) The data 
shown in this study demonstrates a role for klotho in cardioprotection of air pollution-
induced cardiac responses irrespective of diet. Yet, klotho’s role in vitamin D’s cardiac 
effects show that it might protect against the deleterious effects of air pollution 
irrespective of diet. 
Autonomic imbalance is characterized by inappropriate modulation of one of the 
branches of the autonomic nervous system leading to altered homeostatic 
responsiveness and in the case of the cardiovascular system, disease and ultimately 
increased mortality. This has been demonstrated with VDD and following exposures to 
air pollution.(Gold, Litonjua et al. 2000, Pope, Hansen et al. 2004, Brook, Rajagopalan 
et al. 2010, Carll, Lust et al. 2013, Canpolat, Özcan et al. 2015, Farraj, Walsh et al. 
2015) HRV changes occur in susceptible populations such as diabetics, those with 
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hypertension and arrhythmias.(Thayer, Yamamoto et al. 2010) Although VDD has not 
traditionally been identified as increasing susceptibility to cardiovascular disease recent 
data has suggested a correlation, particularly with underlying chronic conditions.(Lee, 
O'Keefe et al. 2008) In this study, VDD mice had decreased HRV, particularly SDNN 
and RMSSD compared to normal mice, even before exposure. This decreased HRV 
response (i.e. relative to normal) was similarly observed during the second and third 
hours of acrolein exposure suggesting that VDD effects autonomic regulation after 
subsequent responses to air pollution. This indicates that VDD causes a shift in 
autonomic function towards greater sympathetic modulation. As stated above, klotho 
significantly decreased SDNN and RMSSD changes in both deficient and normal mice 
suggesting its efficacy is independent of vitamin D levels in the body. 
The protective effect of klotho may be based on its role in calcium regulation, 
reduction of oxidative stress and inflammation, and/or the suppression of cardiac 
muscle pressure-load signaling. Even with normal vitamin D levels, klotho activates 
Na+, K+-ATPase to facilitate transepithelial calcium transport.(Imura, Tsuji et al. 2007, 
Razzaque 2008) Calcium regulation is critical not just in the cardiovascular system but 
throughout the body because overload is a significant risk factor for dysfunction.(Tang, 
Shen et al. 2018) and klotho helps maintain calcium homeostasis under any condition. 
Additionally, klotho inhibits reactive oxygen species production by increasing Nrf2(Zhu, 
Gao et al. 2017) and NF-kB(Guo, Zhuang et al. 2018) pro-inflammatory signaling 
pathways which promotes normal function of the heart. Interestingly, klotho also 
protects the brain against ischemic injuries, such as strokes, through similar 
mechanisms.(Zhou, Li et al. 2017) The brain is believed to be a target of klotho since it 
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is found in cerebrospinal fluid (Kuro-o, Matsumura et al. 1997) and studies suggest that 
the choroid plexus is responsible for its production due to the blood brain 
barrier.(Cararo-Lopes, Mazucanti et al. 2017) Klotho knockouts have neuronal deficits 
(e.g. diminished synapses and axon transport alterations) (Cararo-Lopes, Mazucanti et 
al. 2017) which could feasibly contribute to altered autonomic signaling. Moreover, 
biopsied cardiomyocytes from people with cardiovascular disease showed decreased 
klotho expression and increased FGF-23 signaling, oxidative stress, inflammation and 
fibrosis.(Corsetti, Pasini et al. 2016)  
Although the klotho receptor has not been identified, it is a co-receptor to FGF-23 
to (Dalton, Xie et al. 2017) which is expressed in cardiomyocytes and induced by during 
pressure overload conditions like hypertension.(Leifheit-Nestler, Kirchhoff et al. 2018) 
These data suggest that FGF-23 plays a role in pressure-overload-induced cardiac 
dysfunction and klotho counteracts the response. Although we showed that klotho 
expression in the heart of VDD mice was decreased, it is still unclear whether a similar 
decrease would be observed in normal mice undergoing cardiac stress or hypertrophy 
(e.g. isoproterenol or left anterior descending coronary artery ligation). 
In addition, klotho deficient mice are characterized as having increased vascular 
calcifications suggesting klotho is needed to maintain normal structure and function 
within the vasculature.(Kuro-o, Matsumura et al. 1997) Previous intervention studies 
have shown that when klotho protein is administered intraperitoneally in mice for even a 
short period of time there is a reduction in vascular calcifications.(Chen, Kuro et al. 
2013) A similar response was observed in mutagenic mice with a klotho deletion in 
distal/proximal tubules of the kidney.(Hu, Shi et al. 2011) Thus, the klotho effects on 
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vascular calcification are mediated by calcium and phosphate.(Mencke and Hillebrands 
2017) This data suggests that regardless of diet, klotho can protect against vasculature 
damage due to calcium imbalance. This is pertinent to the findings of this study because 
many of the cardiac effects observed in air pollution studies are secondary to vascular 
or blood pressure changes. 
Furthermore, proper levels of vitamin D and klotho regulate the RAAS pathway 
(by Wnt signaling), this is known to be cardioprotective due to its maintenance of normal 
blood pressure.(Mencke and Hillebrands 2017, Takenaka, Inoue et al. 2017, Eltablawy 
and Ashour 2018) In the RAAS pathway, renin is released by the kidneys (due to direct 
effects of sympathetic nerves, arterial pressure or mineral homeostasis), it then 
catalyzes the conversion of angiotensinogen to angiotensin I. Angiotensin I is then 
converted to angiotensin II by angiotensin converting enzyme (ACE) which is produced 
by the vascular endothelium. The formation of angiotensin II regulates mineral 
homeostasis by the kidneys, vascular constriction to increase pressure and stimulates 
release of aldosterone by the adrenal cortex. Aldosterone release increases sodium and 
fluid retention to restore blood volume or blood pressure.(Yang and Xu 2017) The result 
of these changes is an increase in blood pressure. klotho (as well as vitamin D) has 
been shown to be a negative regulator of RAAS (Li, Kong et al. 2002, Takenaka, Inoue 
et al. 2017) and directly inhibits aldosterone production by the adrenal glands, which 
protects against hypertension and eventually cardiac damage and dysfunction.(Yang 
and Xu 2017) Klotho inhibits RAAS by suppressing angiotensin II and activation of the 
Wnt/β-catenin pathway which in turn has been demonstrated to reduce cardiomyocyte 
damage.(Zhou, Mo et al. 2015, Yu, Meng et al. 2016) In addition, exogenous klotho 
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suppresses mRNA expression of chief RAAS proteins including angiotensinogen, renin 
and ACE to help with blood pressure control.(Zhou, Mo et al. 2015) Future studies 
should evaluate RAAS protein expression in ND and VDD mice and determine whether 
it plays a role in the acrolein-induced cardiac effects.  
Our previous studies have showed that, the HR of mice increases during acrolein 
exposure, probably due to a combination of stress and sensory nerve irritation.(Farraj, 
Hazari et al. 2011, Hazari, Haykal-Coates et al. 2011, Carll, Lust et al. 2013) These data 
show that VDD mice were unable to increase their HR as much as ND mice during the 
first and third hours of acrolein exposure, which is consistent with Takeshita et. al, who 
demonstrated that klotho deficient mice were unable to increase their HR due to stress 
and actually had sinoatrial node dysfunction arrhythmias.(Takeshita, Fujimori et al. 
2004) The inability of VDD mice to increase HR suggests that either the heart is unable 
to respond to normal autonomic signals or that abnormal hemodynamic properties (e.g. 
hypertension) have altered the cardiac function. In either case, klotho blocked these 
changes such that HR during acrolein was completely similar to FA. 
Air pollution also increases cardiac arrhythmias in people and rodents.(Hazari, 
Haykal-Coates et al. 2009, Hazari, Haykal-Coates et al. 2011, Carll, Lust et al. 2013) 
Acrolein increased the total number of arrhythmias particularly during the third hour of 
exposure in both diet groups. Surprisingly, treatment with klotho made it worse. 
Arrhythmias as described here are most typically sinus block or “dropped beats” and not 
premature contractions of the atria or ventricles. We have rarely seen atrial or 
ventricular premature contraction arrhythmias in mice, probably due to their high heart 
rates. Regardless, the higher incidence of arrhythmia due to klotho may be a result of 
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the decreased HR, particularly as observed during the second and third hours of 
exposure. One of the limitations of mouse electrocardiogram is the ability to clearly 
identify a “dropped beat” because the methodology only uses a single lead. On the 
other hand, the dosing scheme for klotho could have possibly activated a divergent 
mechanism resulting in increased arrhythmias given that lower doses of klotho have 
been administered and shown to be efficacious in other studies.(Chen, Kuro et al. 2013) 
Optimization of the dosing scheme using a dose-response would be appropriate for 
future studies. 
Our previous study demonstrated that the diet regimen described is adequate 
time for mice to become VDD.(Stratford, Haykal-Coates et al. 2018) Consistent with 
previous studies, serum calcium and phosphate levels are not different.(Girgis, Cha et 
al. 2015) This result may seem counter intuitive given the known physiological role of 
vitamin D to aid in calcium homeostasis. But serum calcium levels are tightly regulated 
by PTH so further studies should evaluate PTH and the tissue calcium levels, 
particularly in the heart. The heart has a high calcium demand due to its role in 
cardiomyocyte contraction. Therefore, the calcium levels in the heart may be negatively 
affected by VDD and those impairments may be mediated by decreased klotho 
expression.  
As stated previously cardioprotection by klotho has been demonstrated 
previously (Xie, Cha et al. 2012, Song, Gao et al. 2013, Song and Si 2015) but this is 
the first study to demonstrate the cardiac effects of klotho in mice exposed to air 
pollution. Acrolein was used due to its ubiquitous presence in ambient air pollution and 
its known effects on the cardiac autonomic function. Acrolein also activates TRP 
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channels which have also been linked to klotho and VDD. (McNamara, Mandel-Brehm 
et al. 2007, Eke, Igwe et al. 2014) In fact, klotho supplementation reduces the activation 
of TRP channels in response to panful stimuli.(Eke, Igwe et al. 2014) There are still 
questions about whether klotho supplementation could directly target the receptors of 
the nose and lungs or even the heart and are the effects elicited due to upstream 
changes. Klotho is a transmembrane protein that when cleaved functions as a hormone; 
(Imura, Tsuji et al. 2007, Strewler 2007) therefore, it is not unreasonable to speculate 
that the benefits of klotho supplementation could be due to systemic effects including a 
regulatory role on irritant sensor TRP channels in the airways. Additionally, klotho may 
exert its effects by binding to monosialogangliosides in lipid rafts.(Dalton, An et al. 2017) 
 Finally, we previously showed that acrolein exposure alters ventilatory function in 
both mice and rats, which is not surprising given the high concentrations we used and 
irritating nature of the chemical. Although 3ppm of acrolein is not considered even 
remotely close to ambient, such levels can be measured in structural or wildfires. Rats 
exposed to similar concentrations of acrolein had lower breathing frequency and 
increased irritation.(Snow, McGee et al. 2017) Mice exposed to acrolein have similar 
ventilatory responses to acrolein as rats and we showed here that VDD actually further 
increases the rapid (shallow) breathing due to irritation. Klotho appeared to completely 
reverse this phenomenon because mice from both diet groups had significantly 
decreased breathing rates during acrolein. Once again it is not immediately known 
whether these are direct effects in the lungs or secondary to klotho’s regulation of TRP 
channels or some other central neural process. It is worthwhile to note that these 
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ventilatory changes likely influence not only the HR but HRV as well, emphasizing once 
again a systemic shift due to VDD. 
Conclusions 
 This data presented partially indicates that klotho may protect the heart during 
acrolein exposure regardless of whether a person is VDD or not. More importantly, VDD 
modifies the cardiac response to air pollution exposure by modulating the function of the 
ANS and altering breathing. Although these results do not necessarily point to a 
definitive increase in risk, it is still reasonable to conclude that such homeostatic shifts 
can be potentially harmful with other underlying disease or in the event of encountering 
a co-stressor. Regardless, klotho represents potential therapeutic target to protect 
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Chapter 4: Vitamin D Deficiency-Induced Cardiovascular Dysfunction is Mediated 
by TRPC6 
Introduction 
Vitamin D is one of the only micronutrient molecules that is endogenously 
produced in the body and it has a critical homeostatic role across all of the organ 
systems.(Holick 2007, Wang, Pencina et al. 2008) It is a fat-soluble vitamin synthesized 
in the skin after ultraviolent B radiation exposure and acquired through the diet from a 
variety of foods like milk, fish, cheese and vitamin D fortified foods.(Lips 2006, Holick 
2007) Vitamin D receptors are present on numerous tissues and cells throughout the 
body, including cardiomyocytes.(Holick 2007) Vitamin D exerts its effects through a 
steroid nuclear receptor that(Holick 2007, Norman and Powell 2014) upon activation 
forms a complex with the retinoid X receptor.(Fetahu, Höbaus et al. 2014, Saccone, 
Asani et al. 2015) Activated vitamin D receptors (VDR) bind to vitamin D response 
elements (VDRE) on DNA and influence expression of a wide variety of genes covering 
numerous functions (e.g. calcium homeostasis, antioxidant production, protein 
synthesis).(Sundar and Rahman 2011, Fetahu, Höbaus et al. 2014, Norman and Powell 
2014, Saccone, Asani et al. 2015) 
Cardiovascular disease is the leading cause of mortality and morbidity in the 
United States.(Mozaffarian, Benjamin et al. 2016)  Although recent data suggests there 
is a link between VDD and cardiovascular impairment (Wang, Pencina et al. 2008, 
Anderson, May et al. 2010, Masson, Agabiti et al. 2014), the association with 
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cardiovascular disease development is still not firmly established nor is it clear whether 
it contributes to adverse responses due to stress (e.g. air pollution exposure, exercise, 
psychosocial stress). Minimal sun exposure, improper nutrition as well as a myriad of 
other factors result in vitamin D deficiency (VDD) (Holick 2007, Lee, O'Keefe et al. 
2008), which has become a global public health concern affecting 8% of the pediatric 
population in the United States.(Kumar, Muntner et al. 2009) Early-life or childhood VDD 
can lead to vascular dysfunction, hypertension and other cardiac abnormalities(Carlton-
Conway, Tulloh et al. 2004, Maiya, Sullivan et al. 2008, Tare, Emmett et al. 2011), yet 
it’s precise role in electrocardiographic abnormalities and cardiac autonomic and 
mechanical changes has not been extensively characterized.  
Numerous animal and epidemiological studies demonstrate that VDD is 
associated with hypertension.(Li, Qiao et al. 2004, Martins, Wolf et al. 2007, Dobnig, 
Pilz et al. 2008, Giovannucci, Liu et al. 2008, Wang, Pencina et al. 2008, Argacha, 
Egrise et al. 2011, Nigwekar and Thadhani 2013, Weng, Sprague et al. 2013) Vitamin D 
has been shown to be a negative regulator of the renin-angiotensin-aldosterone system 
(RAAS). Previous studies have demonstrated that VDR null mice have continuous 
increased plasma renin expression, which results in increased plasma angiotensin II 
production and hypertension.(Li, Kong et al. 2002) In a study that evaluated the effect of 
VDD on blood pressure in  rats, increases in systolic blood pressure were observed with 
oxidative stress in the vasculature which leads to downregulation of genes involved in 
antioxidant defense and myocardial function.(Argacha, Egrise et al. 2011) Similarly, 
activation of RAAS has also been demonstrated in hypertensive and atherosclerotic 
mouse models fed a VDD.(Weng, Sprague et al. 2013) 
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Transient Receptor Potential Canonical 6 (TRPC6) channels, a subfamily of TRP 
channels, are non-selective cation channels that are expressed in cardiomyocytes and 
vascular smooth muscle cells, among other tissue types, and respond to neurohormonal 
and mechanical stressors.(Rowell, Koitabashi et al. 2010, Loga, Domes et al. 2013, 
Wang, Ma et al. 2016) Increased expression of TRPC6 has previously been linked to 
cardiovascular disease, hypertrophy and hypertension.(Rowell, Koitabashi et al. 2010, 
Watanabe, Iino et al. 2013, Seo, Rainer et al. 2014) For example, mice treated with 
isoproterenol to induce cardiac stress and hypertrophy, similar to a hypertensive state, 
have increased TRPC6 mRNA expression in the heart.(Xie, Cha et al. 2012) TRPC6 is 
also speculated to form a protein complex with other TRPC channels in the heart, 
thereby altering cation flux and muscular contraction.(Xie, Cha et al. 2012, Seo, Rainer 
et al. 2014) However, previous studies suggest that inhibition of TRPC6 alone is 
sufficient for cardioprotection and TRPC6 knockout mice are without obvious 
impairments in function.(Xie, Cha et al. 2012) This data suggests that the limited 
expression of TRPC6 in the heart is normal but it’s presence under conditions of cardiac 
stress is potentially detrimental.(Xie, Cha et al. 2012)  
The TRPC6 antagonist used in the study is a Grammastola spatulata toxin that 
inhibits cationic mechanosensitive ion channels such as TRPC6 and is most effective 
during pathological stress.(Wang, Ma et al. 2016) Previous in vivo studies using 
ischemia-reperfusion injury have demonstrated that TRPC6 antagonist reduced infarct 
area, improved cardiac output and decreased arrhythmias. In addition, cultured mouse 
cardiomyocytes exposed to normal and hypoxic conditions provided evidence that 
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TRPC6 antagonism improved contractility and blocked apoptotic signaling mechanisms 
in the long-term, which may improve cardiomyocyte survival.(Wang, Ma et al. 2016)  
Therefore, the purpose of this study was to determine the role of TRPC6 in VDD-
induced cardiovascular mechanical properties and responses in adult mice. We 
hypothesized that adult mice with persistent VDD would have increased blood pressure 
when compared to normal mice. Furthermore, VDD would cause baseline mechanical 
changes in the heart which are mediated by TRPC6. For the purposes of these 
experiments, dobutamine, which is typically used to mimic cardiac stress of exercise 
was used to increase heart rate and contractility, and thereby reveal underlying changes 
in cardiovascular compensatory mechanisms which may not be evident otherwise.  
Materials and Methods 
Animals - Three-week old female C57Bl/6 mice were used in this study (Jackson 
Laboratory, Raleigh, NC). Mice were housed five per cage and maintained on a 12-hr 
light/dark cycle at approximately 22˚C and 50% relative humidity in an AAA-LAC-
approved facility. Food (Prolab RMH 3000; PMI Nutrition International, St. Louis, MO) 
and water were provided ad libitum during the quarantine period (3 days) after arrival. 
All protocols were approved by the Institutional Animal Care and Use Committee of the 
U.S. Environmental Protection Agency and are in accordance with the National 
Institutes of Health Guides for the Care and Use of Laboratory Animals. The animals 
were treated humanely and with regard for alleviation of suffering. 
Diet - Three days after the quarantine period ended, mice were maintained ad 
libitum on either a vitamin D deficient (VDD) (D10073001-Research Diets Inc.) or 
normal diet (ND) (D10012G-Research Diets Inc.) for 19 weeks. The VDD diet had no 
98 
 
added vitamin D but had vitamin mix V10037. The ND has 1000 IU per 10 grams of 
vitamin D. The diets had equal levels of all other vitamins and minerals including 
calcium, which was at the concentration specified by the American Institute of Nutrition 
(Reeves, Nielsen et al. 1993). Water was provided ad libitum throughout the diet 
regimen. 
Experimental Design and Groups – At the beginning of the study, mice were 
randomly assigned into a ND (n = 20-25) or VDD (n = 20-25) group and maintained on 
those diets for the extent of the study. Of those animals, 9 of the ND and 9 of the VDD 
mice were randomly chosen and implanted with radiotelemeters at 22 weeks of age. 
The remaining mice were used for intraventricular assessments. The design is depicted 
in 4-1.
 
Figure 4-1. Experimental Design. ND and VDD mice were put on their respective diets 
for 19 weeks. A subset of mice, were implanted with radiotelemeters and allowed 7-10 
days to recover and then underwent a dobutamine stress test with 2 doses (0.5 mg/kg 
(low) and 1.5 mg/kg (high). Twenty-four hours later the mice were pre-treated with a 
TRPC6 antagonist (2 mg/kg, i.p.) for 20 minutes prior to repeating the dobutamine 
stress test. The remaining mice were used for intraventricular measurements using a 
Millar pressure probe pre-treated with TRPC6 antagonist for 20 minutes prior to the 
dobutamine stress test. Upon confirming left ventricular placement of the pressure 




Drugs – GsMTx4 (2mg/kg, Tocris, Minneapolis, MN) was dissolved in saline. Two 
doses of freshly diluted dobutamine hydrochloride (Hospira, Lake Forest, IL) were 
administered at concentrations of 0.5 mg/kg (low dose) and 1.5 mg/kg (high dose). 
Previous studies describe increased HR after acute intraperitoneal administration of 
dobutamine.(Tyrankiewicz, Skorka et al. 2013, Puhl, Weeks et al. 2016)  
Surgical Implantation of Radiotelemeters - Animals were anesthetized using 
inhaled isoflurane (Isothesia, Butler Animal Health Supply, Dublin, OH). Anesthesia was 
induced by spontaneous breathing of 2.5% isoflurane in pure oxygen at a flow rate of 1 
L/min and then maintained by 1.5% isoflurane in pure oxygen at a flow rate of 0.5 L/min; 
all animals received the analgesic buprenorphrine (0.03 mg/kg, i.p. manufacturer). 
Briefly, using aseptic technique, each animal was implanted subcutaneously with a 
radiotelemeter (ETA-F10, Data Sciences International, St Paul, MN); the transmitter 
was placed under the skin to the right of the midline on the dorsal side. The two 
electrode leads were then tunneled subcutaneously across the lateral dorsal sides; the 
distal portions were fixed in positions that approximated those of the lead II of a 
standard electrocardiogram (ECG). Body heat was maintained both during and 
immediately after the surgery. Animals were given food and water post-surgery and 
were housed individually. All animals were allowed 7-10 days to recover from the 
surgery and reestablish circadian rhythms (Kurhanewicz, McIntosh-Kastrinsky et al. 
2014). 
Radiotelemetery Data Acquistion - Radiotelemetry methodology (Data Sciences 
International, Inc., St. Paul, MN) was used to track changes in cardiovascular function 
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by monitoring heart rate (HR) and ECG waveforms immediately following telemeter 
implantation and through exposure until the end of exposure. This methodology 
provided continuous monitoring and collection of physiologic data from individual mice 
to a remote receiver. Sixty-second ECG segments were recorded every 15 minutes 
during the 24 hours pre-experiment and immediately (imm.) before dobutamine stress 
test experiment periods and continuously during the experiment; HR was automatically 
obtained from the waveforms (Dataquest ART Software, version 4.0, Data Sciences 
International, St. Paul, MN). Baseline was defined as 4 hours before the start of 
dobutamine stress test. 
Measurement of Intraventricular Pressure – Mice were anesthetized with 
urethane (1.5mg/kg intraperitoneally, Sigma) and then prepared for intraventricular 
measurements. While in a supine position and after achieving the appropriate 
anesthetic plane, the cervical region of the mouse was dissected exposing the right 
carotid artery. After isolation, the artery was catheterized with a 1.4 French transducer 
(SPR-671, ADInstruments, Colorado Springs, CO). The probe was connected via a 
Pressure Control Unit (PCU- 2000) to a receiver (Powerlab 8/30) and a computer 
acquiring data at 1000 Hz (LabChart Pro. 7.3.8) that is depicted in Figure 4-2. The 
probe was advanced while continuously monitoring the pressure trace until entry into 
the left ventricle was confirmed. Once in the left ventricle, a 4-min baseline was 
measured followed by dobutamine administration. Left ventricular pressure (LVP), 
dP/dTmax or the rate of left ventricular pressure rise and dP/dTmin or the rate of left 
ventricular pressure decrease were measured continuously during the baseline period, 
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dobutamine stress test and recovery. Adequate time was allowed for cardiac 
parameters to return to baseline between successive dobutamine doses.  
 
Figure 4-2. Representative example of intraventricular pressure measurements. 
Heart Rate Variability Analysis - Heart rate variability (HRV) was calculated as 
the mean of the differences between sequential RR intervals for the complete set of 
ECG waveforms using ECGAuto. For each 1-min stream of ECG waveforms, mean time 
between successive QRS complex peaks (RR interval), mean HR, and mean HRV-
analysis–generated time-domain measures were acquired. The time-domain measures 
included standard deviation of the time between normal-to-normal beats (SDNN), and 
root mean squared of successive differences (RMSSD). HRV analysis was also 
conducted in the frequency domain using a Fast-Fourier transform. The spectral power 
obtained from this transformation represents the total harmonic variability for the 
frequency range being analyzed. In this study, the spectrum was divided into low-
frequency (LF) and high-frequency (HF) regions. The ratio of these two frequency 
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domains (LF/HF) provides an estimate of the relative balance between sympathetic (LF) 
and vagal (HF) activity. 
Tissue Collection and Analysis – Radiotelemeter implanted mice were 
euthanized 24 hours after dobutamine stress test and blood collected, processed and 
analyzed. Vitamin D concentrations were determined in the serum spectro-
photometrically using a Vitamin D EIA Kit (Cayman Chemical, Ann Arbor, Michigan) and 
previously published (Stratford, 2018).  
Statistics - All data were analyzed using SAS 9.4 (SAS Institute Inc., Cary, NC) 
software. Mixed-model ANOVAs followed by Tukey’s procedure for the post hoc 
comparisons were used to examine the statistical differences between TRPC6 
antagonist and diet and repeated measures analysis was used as needed. The 
statistical significance was set at P < 0.05. 
Results 
Heart rate – Before the start of the dobutamine stress test, the baseline HR of 
ND and VDD mice was similar. Dobutamine caused an increase in the HR of ND mice, 
albeit not in a dose-dependent manner, and the response was significantly decreased in 
VDD mice. Treatment with the TRPC6 antagonist had no effect on the baseline HR of 
either diet group, however, it blocked the reduced response to dobutamine in VDD mice 
making it similar to ND. There was no effect of the drug on the dobutamine response of 




Figure 4-3. Impaired HR rate response to dobutamine in VDD mice is mediated by 
TRPC6. Dobutamine increased HR in ND and VDD mice from baseline but this 
response was significantly decreased in VDD mice. Pre-treatment with the TRPC6 
antagonist restored the decreased response of VDD mice to dobutamine but had no 
effect in ND mice. *significantly different from ND (p < 0.05). ◊significantly different from 
baseline (p < 0.05) Values represent means ± SEM. 
 
Heart rate variability – Before the dobutamine stress test, SDNN (which indicates 
overall autonomic function) and RMSSD, which indicates parasympathetic influence on 
the heart, as well as LF and HF which represent the balance between both autonomic 
branches and other inputs into the heart, were not significantly different between ND 
and VDD mice. Dobutamine caused a decrease in SDNN and LF only at the high dose 
in ND mice, but there were no effects on RMSSD or HF. In contrast, both low and high 
dobutamine caused a significant decrease in SDNN, RMSSD, LF and HF in VDD mice. 
Pretreatment of ND mice with the TRPC6 antagonist caused SDNN and LF to become 
further decreased during dobutamine challenge and caused RMSSD and HF to 
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decrease with the high dose. On the other hand, the TRPC6 antagonist had no effect on 
SDNN in VDD mice but blocked the decreases in LF and HF (Figure 4-4).  
 
 
Figure 4-4. Vitamin D deficiency alters autonomic responses to dobutamine 
stress in mice. There were no differences in SDNN, RMSSD, LF or HF between ND 
and VDD mice at baseline. Dobutamine induced a significant decrease in only SDNN 
and LF at the high dose in ND mice, whereas, low and high dobutamine significant 
decreases in SDNN, RMSSD, LF and HF in VDD mice. Pretreatment of ND mice with 
TRPC6 antagonist induced SDNN and LF to further decrease during dobutamine stress 
test and RMSSD and HF significantly decreased with the high dose. On the other hand, 
TRPC6 antagonist had no effect on SDNN in VDD mice but blocked decrease in LF and 
HF. *significant change from ND (p < 0.05). ◊significantly different from baseline (p < 
0.05) Values represent means ± SEM. 
 
Blood pressure and baseline left ventricular function – There was no difference in 
the diastolic pressure between the diets (Figure 4-5A), however, VDD mice had 
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increased systolic pressure (Figure 4-5B) and mean arterial pressure (Figure 4-5C) 
when compared to ND. Similarly, baseline LVP was increased in VDD mice and the 
response was blocked by the TRPC6 antagonist (Figure 4-5D). The effect of the TRPC6 
antagonist on blood pressure was not measured. 
 
Figure 4-5. Vitamin D deficiency induces increased blood pressure and left 
ventricular pressure in mice. A.) There was no difference in the diastolic pressures of 
ND and VDD mice. However, systolic and mean arterial pressure were significantly 
increased in VDD when compared to controls (B. and C.) D.) Baseline LVP was 
significantly increased in VDD but blocked by TRPC6 antagonist. *significantly different 
from ND (p < 0.05). Values represent means ± SEM. 
 
Left ventricular contractility and relaxation – Figure 4-6 shows the percent 
change in dP/dTmax and dP/dTmin from baseline during dobutamine challenge in ND 
and VDD mice. Low dobutamine increased dP/dTmax or contractility in ND mice, this 
was not significantly different for VDD mice nor did the TRPC6 antagonist have an 
effect on either diet (Figure 4-6A). High dobutamine also caused contractility to increase 
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in ND mice but not as much as the low dose. In contrast, VDD mice had a significantly 
decreased response to the high dose when compared to ND and this effect was blocked 
by the TRPC6 antagonist (Figure 4-6B). Although not statistically significant, VDD mice 
had a trend of decreased dP/dTmin or ventricular relaxation during the dobutamine 
challenge which was not apparent after TRPC6 blockade (Figure 4-6 C-D). 
 
Figure 4-6. Vitamin D deficiency caused alterations in ventricular contractile 
function are mediated by TRPC6. A.) Low dobutamine caused increase in dP/dTmax 
in ND but there was no difference within VDD nor with TRPC6 pretreatment. B.) In 
contrast, VDD mice had significantly decreased responses to high dobutamine when 
compared to ND and the response was blocked by the TRPC6 antagonist. C-D.) VDD 
mice had a trend of decreased dP/dTmin during dobutamine stress test which was not 
apparent after TRPC6 blockade. *significantly different from ND (p < 0.05). Values 







 This study demonstrates that VDD-induced cardiovascular changes in mice are 
mediated by TRPC6. Persistent vitamin D deficiency can result in altered cardiovascular 
responses including autonomic imbalance and hypertension even in otherwise healthy 
adults.(Forman, Bischoff-Ferrari et al. 2005, Wang, Pencina et al. 2008, Canpolat, 
Özcan et al. 2015, Chen, Sun et al. 2015) Although chronic VDD was previously shown 
to increase the risk of hypertension, it was unknown whether there were any cardiac 
changes, either due to direct effects on the heart or as a result of the increased blood 
pressure. In this study, baseline cardiac electrical and mechanical function between 
normal and VDD mice was compared and a dobutamine stress test was used to 
uncover the presence of latent cardiac decrements due to VDD. Indeed, the results 
show that VDD causes increased blood pressure and altered cardiac contractile 
mechanics indicative of impairment and increased risk. Furthermore, this is the first 
study to demonstrate that VDD-induced mechanical changes in the heart are mediated 
by TRPC6, which is known to be involved in the worsening of cardiac hypertrophy.  
Dobutamine is a β1-adrenergic agonist that causes increases in HR and 
contractility that can be compared to the cardiac effects of exercise.(Hazari, Callaway et 
al. 2012, Tyrankiewicz, Skorka et al. 2013, Puhl, Weeks et al. 2016) As such, 
dobutamine was used to unmask latent cardiac effects in mice due to VDD which 
otherwise may not be evident (i.e. during rest). Such tests are used clinically to evaluate 
the cardiac response to stress because an individual is suspected of increased risk of 
adverse cardiac events or having underlying cardiovascular disease, irrespective of the 
presence of symptoms or not.(Iyngkaran, Anavekar et al. 2017) Heart rate is an intrinsic 
and dynamic characteristic of the heart and therefore the degree to which it fluctuates 
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during sudden changes can be a profound indicator of cardiac distress or dysfunction. 
In this study, HR was not significantly different between normal and VDD mice at rest, 
however, the latter had decreased HR responses to both the low and high dose of 
dobutamine (i.e. VDD mice were unable to increase their HR as much as ND mice) 
when compared to normal mice. In a study of middle-aged men, blunted heart rate 
response to exercise was associated with increase cardiovascular mortality.(Savonen, 
Lakka et al. 2006) Furthermore, other pharmacological cardiac stress tests, for instance 
with dipyridamole, have shown the same heightened risk of cardiovascular 
complications when people had a blunted heart rate response,(Mathur, Shah et al. 
2010) which in some cases may be due to under-recruitment of central neural pathways 
that regulate such responses.(Ginty, Gianaros et al. 2013) Chronotropic incompetence, 
which is the inability to raise heart rate commensurate with activity or exertion, can 
represent a serious deficit in the regulatory mechanisms that function to match heart 
rate with need for oxygen. Regardless, this condition likely occurs due to a change in 
the expression of β1-adrenergic receptors or autonomic balance.(Brubaker and Kitzman 
2011) A study of myocardial cells demonstrated that normal β-adrenergic signal 
transduction may rely on the presence of vitamin D both locally (i.e. at the level of the 
heart) as well as centrally.(Santillan, Vazquez et al. 1999) The central influence of 
vitamin D is underscored by the high density of vitamin D receptors in the region of the 
brain where neurons of the autonomic nervous system are located.(Garcion, Wion-
Barbot et al. 2002) In any case, the response observed here does not necessarily 
represent a toxicological effect in the heart, but it does signify that VDD impairs the 
heart’s ability to respond normally to this stressor. 
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 The blunted chronotropic effects of VDD were blocked by the TRPC6 antagonist 
given it restored responsive to dobutamine. Interestingly, the drug had no effect on 
resting heart rate in either normal or VDD mice. This suggests that the role of TRPC6 is 
related to neurohormonal or mechanical stress-induced cardiac changes,(Seo, Rainer 
et al. 2014) which do not necessarily occur under normal physiological circumstances 
but rather during pressure overload and oxidative stress. These latter conditions lead to 
increased influx of calcium into the myocyte and hence altered electrical-mechanical 
properties.(Koitabashi, Aiba et al. 2010) The fact that we did not see a dose-response to 
dobutamine or a more robust response, both with and without the drug, indicates that 
mouse sensitivity to this challenge is quite low.(Tyrankiewicz, Skorka et al. 2013) The 
TRPC6 antagonist used in this study (GsMTx4) prevents and raises the mechanical 
threshold for activation which appropriately explains the restoration of responsiveness 
to dobutamine.(Park, Kim et al. 2008, Xiao, Liu et al. 2017)  
The chief physiological role of TRPC6 in the heart is calcium regulation, 
(Yamaguchi, Iribe et al. 2017) which contributes to pacemaker function (Ahmad, Streiff 
et al. 2017) and stretching of myocardium to allow for ejection of blood against 
mechanical stress(Yamaguchi, Iribe et al. 2017). An increase in TRPC6 expression 
even in the sinoatrial node and right atria(Ferdous, Qureshi et al. 2016) is associated 
with cardiovascular disease,(Rowell, Koitabashi et al. 2010, Loga, Domes et al. 2013, 
Watanabe, Iino et al. 2013) myocardial infarction(Hang, Zhao et al. 2015) and is the 
preliminary event of subsequent heart failure(Yamaguchi, Iribe et al. 2017) which 
contributes to its pathological role. Due to increased TRPC6, calcium and subsequent 
activation of calcineurin is also increased.(Tomilin, Mamenko et al. 2016) Calcineurin is 
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a calcium/calmodulin-dependent serine/threonine protein phosphatase(Bandyopadhyay, 
Lee et al. 2002) and is activated as a result of mechanical stress and sustained 
increased intracellular calcium levels(Yamaguchi, Iribe et al. 2017). Calcineurin 
activates NFAT (nuclear factor of activated T-cells) which is a transcription factor that 
further increases TRPC6 mRNA expression and calcium signaling.(Tomilin, Mamenko 
et al. 2016) In fact, HEK cells overexpressing TRPC6 inhibit Na+, K+-ATPase 
(membrane protein that facilitates transepithelial calcium transport) (Razzaque 2008) to 
decrease calcium signaling as a result of TRPC6 activation and reduce TRPC6 protein 
expression.(Chauvet, Boonen et al. 2015) Increased calcium handling and TRPC6 
expression also increases calcium sensing receptor expression and consequently 
shown to be reversed by vitamin D supplementation.(Bernichtein, Pigat et al. 2017) As 
far as our model is concerned, it is unclear whether vitamin D supplementation would 
reverse the effect of increased TRPC6 mRNA expression on the electrical and 
mechanical function of the heart, whether through the pathway described above or 
otherwise. Calcium is the key mediator in VDD-induced cardiovascular dysfunction and 
increased TRPC6 expression. Future studies need to address the role of calcium 
signaling because it appears to be the key signaling ion in VDD-induced cardiovascular 
dysfunction and increased TRPC6 expression.   
Assessment of heart rate variability also revealed some differences between ND 
and VDD mice. This is not surprising given HRV is influenced not only by HR but also 
blood pressure and respiratory patterns.(Tsuji, Larson et al. 1996) Our previous studies 
have shown that HRV decreased during dobutamine stress test in the rat.(Hazari, 
Callaway et al. 2012) The current data indicate that the same is true for mice, 
111 
 
regardless of whether they are normal or VDD, albeit with variable sensitivity to 
dobutamine. SDNN and LF, both of which indicate sympathetic modulation of the heart, 
appeared to be more decreased during dobutamine challenge in VDD mice than 
normal. A similar trend was observed with RMSSD and HF, which reflect 
parasympathetic modulation. It is not surprising that the VDD-induced LF and HF (i.e. 
frequency domain parameters) changes during dobutamine were blocked by the TRPC6 
antagonist because they represent blood pressure regulation and cyclical breathing 
patterns, respectively(Shaffer and Ginsberg 2017), both of these parameters are known 
to be altered by VDD.  Similar to the HR response, blockade of TRPC6 had no effect on 
any HRV parameter at rest, which supports the contention that physiological changes 
(i.e. blood pressure and breathing rates) during a stress challenge could mediate the 
decreases in LF and HF. Another possible explanation for the efficacy of the TRPC6 
antagonist in blocking the LF and HF in VDD mice is the role TRPC6 plays in 
maintaining mechanical stress-induced vascular tone(Inoue, Jensen et al. 2009), which 
has a direct impact on blood pressure and therefore the variability in heart rate.   
Experimental and epidemiological studies have linked VDD to hypertension in 
people(Li, Kong et al. 2002, Li, Qiao et al. 2004, Scragg, Sowers et al. 2007, Judd, 
Nanes et al. 2008, Carbone, Mach et al. 2014, Zhang, Xu et al. 2017) and based on this 
data the same is true for mice. The blood pressure and assessments were performed 
under anesthesia, thus, blood pressure was lower than the normal range of a conscious 
mouse. Low vitamin D levels impact systolic blood pressure in particular because 
vitamin D increases the activity of endothelial nitric oxide synthase, which leads to the 
synthesis of nitric oxide (NO) and subsequent vasodilation.(Talmor, Golan et al. 2008) 
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Another study showed that vitamin D inhibits the release of vasoconstrictor mediators 
which tend to increase in the absence of NO.(Wong, Delansorne et al. 2010) On the 
other hand, we cannot discount the effects of vitamin D on RAAS, which numerous 
studies have demonstrated is upregulated in the absence of vitamin D.(Tamez, Kalim et 
al. 2013) Yet, with respect to TRPC6, although the antagonist appeared to block the 
increased blood pressure in VDD mice (not shown), such a response is not conclusive 
because we had to make the measurement after dobutamine challenge and withdrawal 
of the probe from the left ventricle. It is conceivable that TRPC6 plays a role in the VDD-
induced hypertension because its expression in vascular smooth muscle in humans and 
rodents is associated with higher blood pressure.(Zou, Xu et al. 2015) Additionally, it 
has been demonstrated that angiotensin II is activated in response to mechanical 
stress, and increased calcium and TRPC6 expression.(Santillan, Vazquez et al. 1999, 
Hang, Zhao et al. 2015) The relationship of VDD and hypertension likely involves the 
RAAS but further examination of the hormones involved in the pathway and in this 
paradigm is needed.  
One of the many deleterious effects of high blood pressure is the impairment of 
left ventricular function. This can lead to altered contractile mechanics and a loss of 
compensatory capacity, particularly when the body is trying to match cardiac output with 
increased demand. To our knowledge, there is no previous study describing the effects 
of VDD on cardiac mechanical function, nor is there any indication whether decrements 
in the heart are due to intrinsic changes or a consequence of higher blood pressure. 
Indeed, VDD mice had increased LVP at rest which offers some insight into how the 
condition might contribute to the development of cardiovascular disease. As mentioned 
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above, these changes may be due to altered vascular tone because the heart needs to 
consistently develop a higher pressure in order to “push” blood out into the vasculature. 
Some evidence points to the uncoupling of NOS and the resulting increase in vascular 
smooth muscle contraction, particularly in the veins, as a cause of increased 
LVP.(Knuckles, Lund et al. 2008) Regardless, elevated baseline LVP can predispose 
the heart to arrhythmia and even failure in the long-term due to hypertrophy.(Lalande 
and Johnson 2010) It also alters the degree to which the heart can increase its 
contractility during periods of stress like the conditions created by dobutamine.  
The fact that blocking TRPC6 attenuated the increased LVP in VDD mice points 
to a cardiac phenomenon in which the heart’s intrinsic contractile properties have 
changed. Xie et al. showed that stress-induced modification of pressure dynamics is 
mediated by TRPC6 and can be blocked by the putative anti-aging protein klotho, which 
consequently mediates the effects of vitamin D.(Xie, Cha et al. 2012) This might explain 
what we observed in the VDD mice because TRPC6 facilitates greater influx of calcium 
into cardiac myocytes during prolonged mechanical stress(Nishida, Watanabe et al. 
2010), which is often a sequelae of hypertension.(Lin, Chang et al. 2014) 
As a result, cardiac contractility was significantly decreased in VDD mice when 
challenged with high dobutamine and was restored by the TRPC6 antagonist, possibly 
due to the restoration of a normal LVP. In contrast, lusitropy was not significantly 
decreased in VDD mice during the challenge although there was a trend towards this 
and recovery with blockade of TRPC6. To determine whether hypertrophy played a role 
in these responses, heart weight was normalized to tibia length and determined to be 
the same for normal and VDD mice indicating that ventricular remodeling and 
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hypertrophy were not yet apparent (data not shown). However, it is unclear if VDD mice 
would eventually develop ventricular remodeling and hypertrophy following a much 
more extended diet regimen. 
Conclusions 
Increased left ventricular pressure was observed in VDD mice and blocked by 
the TRPC6 antagonist. Although diastolic pressure was not statistically significant there 
was a trend of VDD mice having elevated diastolic pressure. Therefore, taking into 
account increased left ventricular, systolic and mean arterial pressure it is certainly likely 
that VDD mice exhibit signs of essential hypertension.(Frohlich and Susic 2012) 
Hypertension is a risk factor for heart failure because it can cause pressure overload 
and when sustained can lead to ventricular remodeling and hypertrophy.(Frohlich and 
Susic 2012)  
In any case, the HR, pressure and contractility changes due to VDD are 
independently significant indicators of increased cardiac risk but when combined 
demonstrate that VDD mice have impaired mechanical cardiac function.(Achinger and 
Ayus 2005, Frohlich and Susic 2012) A wide variety of TRP sub-family members 
respond to calcium influx and are modulated in cardiovascular disease.(Rowell, 
Koitabashi et al. 2010, Watanabe, Iino et al. 2013, Yue, Xie et al. 2015) Although more 
work is still needed to determine the complete mechanism behind VDD-induced 
cardiovascular dysfunction, this study points to the role TRPC6 as a potential mediator 
and therapeutic target of VDD-induced cardiovascular mechanical dysfunction. 
Therapeutic intervention of TRPC6 in renal fibrosis (Wu, Xie et al. 2017) and pulmonary 
hypertension (Malczyk, Erb et al. 2017) is currently being evaluated; thus, inhibition of 
TRPC6 expression could also be examined with respect to cardiovascular disease. 
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Further studies will need to focus on determining the role of calcium signaling in cardiac 
and vascular cells regulated by vitamin D. Regardless, these data contribute to our 
understanding of VDD, particularly if it persists from childhood to adulthood, and the 
specific areas of public health concern and intervention (e.g. hypertension versus 
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Chapter 5: Significance, Conclusions, Future Directions and Implications 
Significance 
Ambient air pollution levels continue to be elevated in certain parts of the world 
and significantly contribute to increased hospitalizations and mortality. Fortunately, 
these levels have drastically decreased in developed countries like the U.S. in the past 
three decades. However, millions of Americans are still living in areas that meet or 
exceed federal regulatory standards for certain pollutants. Thus, air pollution is still an 
environmental public health concern despite the many improvements in technology, use 
of alternative fuels and individual awareness. In addition, susceptible populations and 
individuals with pre-existing cardiovascular conditions (e.g. elderly, hypertensive, 
metabolic-syndrome) have more recently been identified as especially sensitive to the 
adverse health effects of air pollution exposure. (Brook, Rajagopalan et al. 2010) This is 
particularly alarming because there are so many potential factors ranging from genetic 
predisposition to lifestyle to exposure to non-chemical environmental stressors, which 
can modify the development of disease and hence the body’s ability to preserve normal 
function through changing conditions. In 2016, the AHA, in conjunction with several 
federal agencies, reported that heart disease is a significant national public health and 
economic concern and that nutrition was a considerable risk factor for early death or 
disability. In fact, 678,000 deaths, regardless of the cause of mortality, in 2010 were 
attributed to poor nutrition. (Mozaffarian, Benjamin et al. 2016)   
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Adverse health effects due to air pollution have been studied for well over half a 
century and these investigations are still relevant today because extreme episodes (e.g. 
wildfires) continue to occur each year. The initial study described in this dissertation 
examined whether persistent VDD in adult mice altered the cardiac response to 
atmospheric photochemical smog, which is a relevant multipollutant mixture similar in 
composition to the ambient air pollution found in many urban centers in the United 
States. The importance of this initial study is underscored by the fact that millions of 
people across the world suffer from VDD and many of them are routinely exposed to 
smog, increasing the risk of potential adverse cardiac responses. Our previous studies 
demonstrated that a smog atmosphere comprised of high ozone (and other gases) and 
low PM was more cardiotoxic to normal mice than one that had high PM and low ozone. 
(Hazari and Stratford 2018) Therefore, the goal of my work, as presented in chapter 
two, was to determine whether VDD further modified the cardiac effects due to PM-
enriched smog such that the changes would be similar to ozone-enriched smog. 
Subsequent investigations (i.e. chapters 3) used a different approach and built on the 
findings of greater acute cardiac effects due to a predominantly gaseous smog 
atmosphere. These gases are extremely irritating to the airways and we have 
repeatedly demonstrated that they are responsible for potent cardiac effects through 
modulation of autonomic function. (Hazari, Griggs et al. 2014, Kurhanewicz, McIntosh-
Kastrinsky et al. 2014, Conklin, Haberzettl et al. 2017) Therefore, acrolein, a ubiquitous 
reactive aldehyde and gaseous pollutant, was used to elicit acute cardiac effects 
because of its known ability to activate autonomic reflex arcs. This in turn was deemed 
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to be a suitable approach to assess whether the effects of VDD on homeostatic controls 
like the autonomic nervous system would predispose mice to modified responsiveness.  
Proper function and regulation of the cardiovascular system depends on 
adequate levels of micronutrients like vitamin D. Vitamin D is required for calcium and 
phosphate homeostasis which are crucial for countless skeletal and non-skeletal bodily 
functions. Vitamin D deficiency affects approximately one billion people worldwide and 
is a global public health concern, however, the causes of VDD vary and the resulting 
deficits can range from high blood pressure to depression, rickets and even cancer. 
(Holick 2007)  Vitamin D was chosen as an initial prototype micronutrient deficiency due 
to its known cardiovascular effects and immense public health relevance. Furthermore, 
the occurrence of VDD in people living in places where air pollution is a serious concern 
(e.g. New Delhi, India) is quite high and represents an important interaction that has yet 
to be properly characterized. Vitamin D deficiency also disproportionately affects certain 
nationalities and people residing in areas with longer winters, and for many of these 
people it begins early in life and can persist into adulthood. So, the work described in 
this dissertation attempted to understand early-life physiological changes due to VDD, 
and susceptibility to chronic disease during adulthood. Although these studies focused 
on post-weaning VDD, an interesting alternative paradigm could have been an 
investigation into the effects of maternal and in-utero VDD on the development of 
adverse cardiovascular responses. 
The potential for adverse responses due to VDD are substantial given the 
vitamin’s general activity throughout the body. As far as the cardiovascular system is 
concerned, most studies suggest that VDD leads to hypertension, however, with the 
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caveat that other factors clearly play a role as well. Blood pressure is increased even in 
individuals with VDD without hypertension (Forman, Bischoff-Ferrari et al. 2005) which 
confirms that the condition on its own may not be sufficient to cause pathological high 
blood pressure. In relation, VDD also affects signaling in the brain and downstream 
autonomic imbalance, which leads to impaired regulation of cardiac function (Canpolat, 
Özcan et al. 2015), demonstrating that vitamin D is centrally neuroactive (Wadhwania 
2017). In fact, a study reported that individuals with VDD had impaired autonomic 
balance at rest and those with the lowest levels of serum 1,25-dihydroxy vitamin D had 
had “unfavorable” cardiac activity during a stress challenge. (Mann, Exner et al. 2013) It 
is not surprising that the mechanisms underlying the VDD-induced adverse 
physiological changes are quite varied because the autonomic nervous system is itself 
regulated by numerous central signals and innervates virtually every tissue type in the 
body. Almost 15 years ago the AHA recognized that vitamin D inhibits oxidative stress 
and inflammation and recommended dietary supplementation in people at risk for 
cardiovascular disease. (Kris-Etherton, Akabas et al. 2014) Therefore, the findings 
presented in this dissertation confirm the cardiac effects of VDD and begin to elucidate 
how it might be involved in altered responsiveness to air pollution exposure.  
The human body experiences numerous stressors during the course of a day 
that usually will not cause adverse responses. Persistent deficits in the nutritional state 
of the body and/or repeated insults that prevent the body from recovery can significantly 
hamper the ability to maintain homeostasis. Indeed, even with repeated insults, proper 
nutritional intake can mitigate the development of dysfunction. As such, VDD has been 
shown to play a role in aging disorders due to subtle changes in calcium signaling 
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subsequently leading to calcium deposits that contribute to the formation of reactive 
oxygen species, cognitive impairment and adverse cardiovascular impacts including 
toxicity. (Berridge 2016) On the other hand, vitamin D repletion could stimulate cardiac 
cell differentiation and improve recovery from infarct injury. (Hlaing, Garcia et al. 2014) 
Yet, when the body is both nutritionally deprived and exposed to potentially 
damaging stimuli then the risk of disease increases significantly. The work described in 
this dissertation is the first to demonstrate that early-life persistent VDD alters the 
cardiovascular response to air pollution and potentially predisposes the heart to 
dysfunction due to a mismatch in the availability of vitamin D and the requirements of a 
particular organ. Several studies have demonstrated that individual vitamin D status 
determines the response to stress and critical illness. (Lucidarme, Messai et al. 2010, 
Kestenbaum, Katz et al. 2011, Lee 2011) However, under certain circumstances it is not 
necessarily the absolute level of vitamin D in the body that determines if a stress-
induced adverse response occurs or not, but rather whether enough active vitamin D is 
made available to suffice a given tissue’s need at that moment. (Quraishi and Camargo 
2012) Furthermore, hypocalcemia is common under conditions of stress or critical 
illness and can cause a rise in PTH, which would increase conversion of inactive 
vitamin D to active vitamin D to maintain calcium homeostasis. In this setting, the rapid 
consumption of inactive vitamin D due to secondary hyper-parathyroidism would further 
exacerbate VDD. This is supported by studies that have showed that acutely stressed 
or ill patients have secondary hyperparathyroidism with hypocalcemia and VDD. 
(Lucidarme, Messai et al. 2010, Flynn, Zimmerman et al. 2012) 
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Therefore, three-week-old mice were put on a normal or vitamin D deficient diet 
for 16-19 weeks and cardiopulmonary function was evaluated after a subsequent 
stressor (e.g. air pollution exposure or dobutamine stress test). The initial study 
objective was to characterize the cardiopulmonary response of VDD after a complex, 
realistic, multipollutant exposure. A major component of the multipollutant was then 
chosen as a single-pollutant exposure to determine the cardiopulmonary response in 
the context of a potential vitamin D mediator called klotho. Lastly, the impact of early-life 
VDD on mechanical cardiac function was determined in adult mice and the role of 
TRPC6, which is a cation channel expressed in the heart, was assessed with respect to 
it. These data describe mechanisms of underlying cardiovascular dysfunction due to 
VDD that are modified by a subsequent stressor. Taken together, these results highlight 
the influence of nutritional factors in determining murine responses to air pollution. If 
present in people, these effect modifications could have significant relevance to public 
health. 
Principal Conclusions 
Early-Life Persistent Vitamin D Deficiency Alters Cardiopulmonary Responses to 
Particulate Matter-Enhanced Atmospheric Smog in Adult Mice. 
The objective of this study was to determine the effect of early-life persistent 
VDD on cardiopulmonary responses to a photochemical smog composed of high PM 
and low pollutant gases like ozone. The results demonstrate that VDD modulates the 
adverse cardiovascular response of adult mice to a single air pollution exposure. 
Although body weight was similar between normal and VDD mice, VDD mice had 
decreased HR, increased HRV and decreased tidal volume when compared to controls. 
In addition, VDD appeared to blunt the normal increase in tidal volume from five to 
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fifteen weeks of age. Smog had variable effects on normal and deficient mice. Heart 
rate decreased during air exposure, this response was blunted by smog in ND mice and 
to a lesser degree in VDD (i.e. HR remained more elevated in VDD). Smog exposure 
also further potentiated the increased HRV in VDD mice and increased cardiac 
arrhythmias only in ND mice. The findings of this study show that VDD modifies the 
cardiopulmonary effects of smog exposure; thus, highlighting the possible impact of 
nutritional factors on the responsiveness of the body to environmental stressors. 
Although the effects described in this study do not necessarily represent a clinical 
disease or pathological processes, they do represent a shift in the homeostatic control 
mechanisms of the body such that there is a potential for impaired compensation and 
maintenance of equilibrium. This is important to consider because the absence of 
significant symptoms and clinical presentation does not necessarily mean the absence 
of risk.  
Klotho blocks heart rate and heart rate variability changes in early-life persistent 
vitamin D deficient mice during acrolein exposure 
Acrolein is a ubiquitous gas found in complex air pollution mixtures like smog and 
it is known to contribute to adverse cardiovascular health effects. Yet, those effects in 
the presence of underlying nutritional deficiency, as well as the mechanisms underlying 
them, are still unknown. Acrolein elicits its cardiovascular effects in part through the 
activation of airway sensory nerves and subsequent modulation of autonomic function. 
Adequate levels of essential micronutrients like vitamin D are necessary to maintain 
autonomic balance and proper regulation of cardiac function. Studies have revealed that 
vitamin D exerts some of its effects in the body through klotho, which is an anti-aging 
130 
 
transmembrane protein that is cleaved into a soluble form and is secreted into the blood 
and cerebrospinal fluid.  Consequently, klotho effects numerous cell tissues including 
the heart and is reduced in VDD. Therefore, the goal of this study was to determine the 
role of klotho in early-life VDD- induced adverse cardiac responses to acrolein in adult 
mice. Prior to exposure, HR was increased and HRV was decreased in VDD mice when 
compared to ND mice. When compared to FA exposure, HR and HRV significantly 
increased during acrolein in both ND and VDD mice. However, HR and HRV were 
significantly lower in VDD mice when compared to ND during acrolein exposure. 
Interestingly, klotho blocked the acrolein-induced HR response in both ND and VDD 
mice. Acrolein also increased arrhythmias, decreased breathing frequency and 
increased ventilatory irritation in both ND and VDD mice. Klotho administration 
unexpectedly caused the arrhythmias to increase in both diet groups and altered the 
breathing response. Therefore, VDD modifies the cardiac response of mice to acrolein 
through a mechanism involving klotho, however, contrary to what we expected, 
treatment with klotho appears to “benefit” normal mice during acrolein exposure as well.  
Although additional studies are needed to verify these findings, these data suggest 
klotho treatment could potentially lessen the effects of air pollution in people in general, 
but particularly in those with VDD. 
Cardiac mechanical dysfunction due to vitamin D deficiency is mediated by 
TRPC6 
Vitamin D modulates transient receptor potential (TRP) channel expression and 
function, and both have significant implications in cardiac physiology. However, it is still 
unknown whether VDD induces any cardiac contractile effects or if TRP channels are 
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involved. As such, it is believed that the impact of VDD on the heart occurs due to 
hypertension and pressure overload on the heart. Transient Receptor Potential C6 
(TRPC6) is a mechanosensitive ion channel found in the heart and its overexpression 
has been linked to certain cardiovascular diseases. Blockade of TRPC6 improves 
cardiac output and contractility in vivo and in vitro, respectively, following 
ischemia/reperfusion cardiac injury. Yet, the role of TRPC6 on cardiac mechanical 
responses of VDD mice is unknown. Compared to ND mice, VDD mice had higher 
blood pressure and a blunted HR response during dobutamine stress test, which was 
restored when they were treated with the TRPC6 antagonist. Increased left ventricular 
pressure and decreased contractility in VDD mice were also restored by TRPC6 
antagonist, whereas there was no change in normal mice. Heart rate variability was 
decreased in VDD mice during dobutamine stress testing, but TRPC6 antagonism had 
no effect. Thus, TRPC6 mediates VDD-induced mechanical cardiovascular dysfunction 
and altered responsiveness to an exercise-like stressor, but future studies with a 
prolonged diet regimen are needed to evaluate whether TRPC6 contributes to 











Figure 5.1. Potential pathway of the cardiac effects due to VDD. 
A proposed pathway for the cardiac effects due to VDD is demonstrated in Figure 
5-1. Modifiable factors such as diet, can influence systemic responses to everyday 
stressors like exercise, air pollution exposure or even non-chemical insults like noise. 
The studies presented in this dissertation, clearly demonstrate that VDD represents a 
potential modifiable factor that under certain conditions primes the cardiovascular 
system to an adverse response. Although VDD mice have increased blood pressure, 
altered autonomic balance and cardiac mechanical changes it is only during a stressful 
challenge (e.g. exercise/dobutamine or air pollution) that these latent effects are 
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revealed. Some of these effects appear to be mediated by klotho and TRPC6, which 
depend on adequate levels of vitamin D for proper physiological function. Previous data 
on TRPC6 and klotho conclusively demonstrate that sustained increased calcium is a 
direct effect of TRPC6 and klotho actions on the heart. Although this dissertation did not 
directly examine the role of calcium, it is likely to be a key mediator in this response 
given the actions of TRPC6, klotho and vitamin D and future studies should be 
performed to further evaluate its role. Changes in the activity of nitric oxide synthase 
(NOS) and RAAS activation have also been demonstrated to affect calcium signaling, 
particularly in the vasculature, and certainly represent an area that needs further 
investigation. 
When increased calcium is sustained, adverse cardiac effects are experienced 
including autonomic imbalance, mechanical dysfunction (e.g. decrements in contractility 
and lusitropy) and hypertension. This dissertation does not explicitly examine vascular 
calcification but previous studies suggest that these effects result from increased 
calcium as well and may contribute to the overall syndrome. The data presented in this 
dissertation cannot fully explain the increase in arrhythmias due to VDD or klotho 
treatment, which may involve modulation of other channels involved in the cardiac 
action potential (e.g. Na+ channels). Finally, stress is ubiquitous and likely involves 
other regulatory pathways in the body and these could also alter the cardiac effects 
induced by VDD. 
Future Directions 
The body constantly monitors blood calcium levels to ensure adequate levels for 
the maintenance of normal physiology. Calcium dysregulation and inadequacy results in 
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aberrant processes in the body which cannot be sustained. The serum calcium and 
phosphate findings presented in this dissertation are consistent with previous studies 
(Girgis, Cha et al. 2015) but serum levels are tightly regulated and may not reflect 
deficits in intracellular calcium signaling. Future studies should evaluate PTH levels to 
get a better understanding of overall calcium homeostasis and regulation attributed to 
VDD. In persistent and severe VDD, PTH and calcium levels would also be decreased. 
Furthermore, the kidney, brain and heart are tissues with increased calcium demand 
and can be negatively affected by VDD. Understanding the differential effect of VDD 
and calcium availability in each of these tissues would help to determine calcium’s 
contribution to cardiovascular disease.  
Increased intracellular calcium levels may result from modulation of TRPC6 and 
klotho. As depicted in Figure 5-1, increased TRPC6 and decreased klotho result in 
increased calcium through activation of calcineurin/NFAT pathway and increased Na+-
K+-ATPase recruitment to the plasma membrane respectively. Determining the activity 
of the calcineurin/NFAT pathway in this model would demonstrate that increased 
TRPC6 causes increased intracellular calcium signaling. As such, demonstrating 
increased protein expression of Na+-K+-ATPase will also establish a mechanism of 
increased calcium through klotho resulting in adverse cardiac responses. Additionally, 
electrophysiology experiments using TRPC6 inhibitors (McPate, Bhalay et al. 2014) or 
even calcium channel blockers would determine the role of cation channels in VDD-
induced cardiac dysfunction. The role of calcium through TRPC6 and klotho in this 




Clinically, vitamin D supplementation is regularly recommended in order to 
restore VDD to normal levels likely due to the known bone effects especially in children. 
A myriad of studies examining vitamin D supplementation in relation to heart disease 
have been conducted and mostly inconclusive unfortunately. (Muscogiuri, Annweiler et 
al. 2017) For example, studies have demonstrated that vitamin D supplementation has 
no effect on inflammation in heart failure patents (Mousa, Naderpoor et al. 2017, 
Rodriguez, Mousa et al. 2018) or insulin sensitivity in obesity (Mousa, Naderpoor et al. 
2017), even with a wide variety of dosing regimens. Vitamin D supplementation had no 
effect on blood pressure (Arora, Song et al. 2015), hospital admissions after ischemic 
injury (Harvey, D'Angelo et al. 2018) and prevention of heart failure (D'Amore, Marsico 
et al. 2017) or cardiovascular disease (Scragg, Stewart et al. 2017). However, current 
clinical trials are being conducted in a more focused manner to determine the effect of 
vitamin D supplementation (with or without omega-3 fatty acids) in the prevention of 
cardiovascular disease. (Pradhan and Manson 2016)  
On the other hand, previous studies have intraperitoneally administered klotho 
and found that klotho diminished calcium accumulations in the kidneys and aorta, which 
may protect mice against disorders (i.e. vascular calcifications) associated with age. 
(Chen, Kuro et al. 2013) However, it is not currently known if and how cardiomyocytes 
uptake exogenous klotho to subsequently exert cardioprotective effects. A klotho 
receptor has not been identified but may be involved in its downstream cardioprotective 
effects through lipid rafts. (Dalton, An et al. 2017, Mencke and Hillebrands 2017) Dose 
optimization of klotho is also needed and may vary per diet regimen. 
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Increased TRPC6 mRNA expression in the heart was suggested in this work and 
it has been published previously and linked to cardiovascular disease. (Watanabe, 
Murakami et al. 2009, Xie, Cha et al. 2012, Watanabe, Iino et al. 2013, Yamaguchi, Iribe 
et al. 2017) Despite the increased TRPC6 in the heart with VDD, numerous questions 
remain, including: 1) are the increased channels functionally active, 2) is the threshold 
for their activation altered due to changes in hemodynamics and 3) how is calcium 
handling modulated and contributing to adverse cardiac responses.  
As such, vitamin D and klotho are both negative regulators of RAAS contributing 
to anti-hypertensive and cardioprotective effects. (Li, Kong et al. 2002, Takenaka, Inoue 
et al. 2017) In fact, renin production is blocked by vitamin D to regulate blood pressure. 
(Trehan, Afonso et al. 2017) Therefore, an important step in determining the impact of 
VDD on cardiovascular disease development would be to evaluate the components of 
RAAS (e.g. angiotensinogen, renin, angiotensin 1 and 2 and angiotensin converting 
enzyme) and how they contribute to dysfunction.   
Finally, the work presented here can be taken a step further would to examine a 
heart failure murine model such as ischemia-reperfusion injury, isoproterenol-stress or 
even left ascending coronary artery ligation to assess how early-life persistent VDD 
modifies the cardiovascular response to these stressors. Each of these procedures 
represent a common cardiac injury, which are also present in humans and known to 
impair overall cardiac function. Using the regimen described here, normal and VDD 
mice could undergo one of these cardiac injury procedures to determine the extent of 
the response and thereafter the response to air pollution. In all of the studies presented 
in this dissertation, the mice were healthy when exposed to the stressor and therefore, 
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further understanding of the influence of micronutrient deficiency on cardiac response to 
stress after an injury (e.g. myocardial infarct) is critical. 
Implications 
Studies have used klotho and TRPC6 as biomarkers or therapeutics and the 
work presented here provides further evidence for the utilization of klotho and TRPC6 
as potential therapeutic targets. Additional studies are needed to validate klotho as a 
potential nutritional supplement irrespective of diet and TRPC6 antagonism in 
preventing cardiovascular disease. This body of work is the first to demonstrate that 
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